# EDGAR Filing Document

**Accession Number:** 0000849869
**File Stem:** 0001628280-26-031008
**Filing Date:** 2026-5
**Character Count:** 155718
**Document Hash:** 6b90cfc868142ef872c41aebe4834074
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001628280-26-031008.hdr.sgml**: 20260506

**ACCESSION NUMBER**: 0001628280-26-031008

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 67

**CONFORMED PERIOD OF REPORT**: 20260331

**FILED AS OF DATE**: 20260506

**DATE AS OF CHANGE**: 20260506

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** SILGAN HOLDINGS INC
- **CENTRAL INDEX KEY:** 0000849869
- **STANDARD INDUSTRIAL CLASSIFICATION:** METAL CANS [3411]
- **ORGANIZATION NAME:** 04 Manufacturing
- **EIN:** 061269834
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-41459
- **FILM NUMBER:** 26946790

**BUSINESS ADDRESS:**
- **STREET 1:** 601 MERRITT 7
- **CITY:** NORWALK
- **STATE:** CT
- **ZIP:** 06851
- **BUSINESS PHONE:** 2039757110

**MAIL ADDRESS:**
- **STREET 1:** 601 MERRITT 7
- **STREET 2:** FLOOR 1
- **CITY:** NORWALK
- **STATE:** CT
- **ZIP:** 06851

?xml version='1.0' encoding='ASCII'? slgn-20260331

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

**FORM 10-Q** 

(Mark One)

 ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2026

OR

 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ________________ to ________________

Commission file number 001-41459

**SILGAN HOLDINGS INC.** 

(Exact name of Registrant as specified in its charter)

---

| | | |
|:---|:---|:---|
| Delaware | Delaware | 06-1269834 |
| (State or other jurisdiction | (State or other jurisdiction | (I.R.S. Employer |
| of incorporation or organization) | of incorporation or organization) | Identification No.) |
| 601 Merritt 7 | 601 Merritt 7 | |
| Norwalk, | Connecticut | 06851 |
| (Address of principal executive offices) | (Address of principal executive offices) | (Zip Code) |

---

(203) 975-7110

(Registrant's telephone number, including area code)

N/A

(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
| Common Stock, par value $0.01 per share | SLGN | New York Stock Exchange |

---

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the Registrant has submitted electronically every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the Registrant was required to submit and post such files). Yes ☒ No ☐

Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

---

| | | | |
|:---|:---|:---|:---|
| Large accelerated filer | ☒ | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Accelerated filer | ☐ |
| Non-accelerated filer | ☐ | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Smaller reporting company | ☐ |
| | | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Emerging growth company | ☐ |

---

If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

As of April 30, 2026, the number of shares outstanding of the Registrant's common stock was 105,679,758.

------

---

| | |
|:---|:---|
| SILGAN HOLDINGS INC. | SILGAN HOLDINGS INC. |
| **TABLE OF CONTENTS** | **TABLE OF CONTENTS** |
| | <u>Page No.</u> |
| <u>[Part I. Financial Information](#ib0f7994898d643099069869ba15e9e7d_10)</u> | <u>[3](#ib0f7994898d643099069869ba15e9e7d_10)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Item 1.&nbsp;&nbsp;&nbsp;&nbsp;Financial Statements](#ib0f7994898d643099069869ba15e9e7d_13)</u> | <u>[3](#ib0f7994898d643099069869ba15e9e7d_13)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Condensed Consolidated Balance Sheets at](#ib0f7994898d643099069869ba15e9e7d_16)[March](#ib0f7994898d643099069869ba15e9e7d_16)[3](#ib0f7994898d643099069869ba15e9e7d_16)[1](#ib0f7994898d643099069869ba15e9e7d_16)[, 202](#ib0f7994898d643099069869ba15e9e7d_16)[6](#ib0f7994898d643099069869ba15e9e7d_16)[and 202](#ib0f7994898d643099069869ba15e9e7d_16)[5](#ib0f7994898d643099069869ba15e9e7d_16)[and December 31, 202](#ib0f7994898d643099069869ba15e9e7d_16)[5](#ib0f7994898d643099069869ba15e9e7d_16)</u> | <u>[3](#ib0f7994898d643099069869ba15e9e7d_16)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Condensed Consolidated Statements of Income for the three](#ib0f7994898d643099069869ba15e9e7d_19)[months ended](#ib0f7994898d643099069869ba15e9e7d_19)[March 31](#ib0f7994898d643099069869ba15e9e7d_19)[, 202](#ib0f7994898d643099069869ba15e9e7d_19)[6](#ib0f7994898d643099069869ba15e9e7d_19)[and 202](#ib0f7994898d643099069869ba15e9e7d_19)[5](#ib0f7994898d643099069869ba15e9e7d_19)</u> | <u>[4](#ib0f7994898d643099069869ba15e9e7d_19)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Condensed Consolidated Statements of Comprehensive Income for the three](#ib0f7994898d643099069869ba15e9e7d_22)[months ended](#ib0f7994898d643099069869ba15e9e7d_22)[March 31, 2026](#ib0f7994898d643099069869ba15e9e7d_22)[and 202](#ib0f7994898d643099069869ba15e9e7d_22)[5](#ib0f7994898d643099069869ba15e9e7d_22)</u> | <u>[5](#ib0f7994898d643099069869ba15e9e7d_22)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Condensed Consolidated Statements of Cash Flows for the](#ib0f7994898d643099069869ba15e9e7d_25)[three](#ib0f7994898d643099069869ba15e9e7d_25)[months ended](#ib0f7994898d643099069869ba15e9e7d_25)[March 31](#ib0f7994898d643099069869ba15e9e7d_25)[, 202](#ib0f7994898d643099069869ba15e9e7d_25)[6](#ib0f7994898d643099069869ba15e9e7d_25)[and 202](#ib0f7994898d643099069869ba15e9e7d_25)[5](#ib0f7994898d643099069869ba15e9e7d_25)</u> | <u>[6](#ib0f7994898d643099069869ba15e9e7d_25)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Condensed Consolidated Statements of Stockholders' Equity for the three](#ib0f7994898d643099069869ba15e9e7d_28)[months ended](#ib0f7994898d643099069869ba15e9e7d_28)[March 31](#ib0f7994898d643099069869ba15e9e7d_28)[, 202](#ib0f7994898d643099069869ba15e9e7d_28)[6](#ib0f7994898d643099069869ba15e9e7d_28)[and 202](#ib0f7994898d643099069869ba15e9e7d_28)[5](#ib0f7994898d643099069869ba15e9e7d_28)</u> | <u>[7](#ib0f7994898d643099069869ba15e9e7d_28)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Notes to Condensed Consolidated Financial Statements](#ib0f7994898d643099069869ba15e9e7d_31)</u> | <u>[8](#ib0f7994898d643099069869ba15e9e7d_31)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Item 2.&nbsp;&nbsp;&nbsp;&nbsp;Management's Discussion and Analysis of Financial Condition and Results of Operations](#ib0f7994898d643099069869ba15e9e7d_82)</u> | <u>[18](#ib0f7994898d643099069869ba15e9e7d_82)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Item 3.&nbsp;&nbsp;&nbsp;&nbsp;Quantitative and Qualitative Disclosures About Market Risk](#ib0f7994898d643099069869ba15e9e7d_97)</u> | <u>[27](#ib0f7994898d643099069869ba15e9e7d_97)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Item 4.&nbsp;&nbsp;&nbsp;&nbsp;Controls and Procedures](#ib0f7994898d643099069869ba15e9e7d_100)</u> | <u>[27](#ib0f7994898d643099069869ba15e9e7d_100)</u> |
| <u>[Part II. Other Information](#ib0f7994898d643099069869ba15e9e7d_103)</u> | <u>[28](#ib0f7994898d643099069869ba15e9e7d_103)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Item 5.&nbsp;&nbsp;&nbsp;&nbsp;Other Information](#ib0f7994898d643099069869ba15e9e7d_109)</u> | <u>[28](#ib0f7994898d643099069869ba15e9e7d_109)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Item 6.&nbsp;&nbsp;&nbsp;&nbsp;Exhibits](#ib0f7994898d643099069869ba15e9e7d_112)</u> | <u>[28](#ib0f7994898d643099069869ba15e9e7d_112)</u> |
| <u>[Signatures](#ib0f7994898d643099069869ba15e9e7d_115)</u> | <u>[29](#ib0f7994898d643099069869ba15e9e7d_115)</u> |

---

------

Part I. Financial Information

Item 1. Financial Statements

**SILGAN HOLDINGS INC.** 

**CONDENSED CONSOLIDATED BALANCE SHEETS**

(Dollars in thousands)

---

| | | | |
|:---|:---|:---|:---|
| | March 31, 2026 | March 31, 2025 | Dec. 31, 2025 |
| | (unaudited) | (unaudited) | |
| **Assets** |  |  |  |
| Current assets: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cash and cash equivalents | $435429 | $353030 | $1080659 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Trade accounts receivable, net | 1158680 | 1012790 | 589400 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Inventories | 1128749 | 1055281 | 1080134 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Prepaid expenses and other current assets | 243910 | 176369 | 241725 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current assets | 2966768 | 2597470 | 2991918 |
| Property, plant and equipment, net | 2355014 | 2302690 | 2378331 |
| Goodwill | 2465017 | 2373376 | 2486678 |
| Other intangible assets, net | 878969 | 889865 | 900083 |
| Other assets, net | 656511 | 604574 | 640073 |
|  | $9322279 | $8767975 | $9397083 |
| **Liabilities and Stockholders' Equity** |  |  |  |
| Current liabilities: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Revolving loans and current portion of long-term debt | $988323 | $1145091 | $631632 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Trade accounts payable | 817034 | 736823 | 1251889 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accrued payroll and related costs | 120506 | 119477 | 121168 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accrued liabilities | 431920 | 283940 | 447180 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current liabilities | 2357783 | 2285331 | 2451869 |
| Long-term debt | 3672124 | 3483472 | 3715216 |
| Deferred income taxes | 515999 | 486824 | 501768 |
| Other liabilities | 455776 | 429004 | 453929 |
| Stockholders' equity: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Common stock | 1751 | 1751 | 1751 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Paid-in capital | 389325 | 371207 | 384847 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Retained earnings | 3645564 | 3448952 | 3605043 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accumulated other comprehensive loss | (206209) | (303386) | (213556) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Treasury stock | (1509834) | (1435180) | (1503784) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total stockholders' equity | 2320597 | 2083344 | 2274301 |
|  | $9322279 | $8767975 | $9397083 |

---

See accompanying notes.

------

**SILGAN HOLDINGS INC.**

**CONDENSED CONSOLIDATED STATEMENTS OF INCOME**

For the three months ended March 31, 2026 and 2025

(Dollars and shares in thousands, except per share amounts)

(Unaudited)

---

| | | |
|:---|:---|:---|
| | 2026 | 2025 |
| Net sales | $1561258 | $1466661 |
| Cost of goods sold | 1295481 | 1196258 |
| &nbsp;&nbsp;&nbsp;&nbsp;Gross profit | 265777 | 270403 |
| Selling, general and administrative expenses | 131175 | 129087 |
| Rationalization charges | 9047 | 10959 |
| Other pension and postretirement (income) | (1040) | (187) |
| &nbsp;&nbsp;&nbsp;&nbsp;Income before interest and income taxes | 126595 | 130544 |
| Interest and other debt expense before loss on <br>&nbsp;&nbsp;&nbsp;&nbsp;early extinguishment of debt | 41432 | 42928 |
| Loss on early extinguishment of debt | 1017 |  |
| Interest and other debt expense | 42449 | 42928 |
| &nbsp;&nbsp;&nbsp;&nbsp;Income before income taxes | 84146 | 87616 |
| Provision for income taxes | 22305 | 20816 |
| &nbsp;&nbsp;&nbsp;&nbsp;Income before equity in earnings of affiliates | 61841 | 66800 |
| Equity in earnings of affiliates, net of tax | 1198 | 1162 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net income | $63039 | $67962 |
| Earnings per share:  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Basic net income per share | $0.60 | $0.64 |
| &nbsp;&nbsp;&nbsp;&nbsp;Diluted net income per share | $0.60 | $0.63 |
| Weighted average number of shares: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Basic | 105590 | 106915 |
| &nbsp;&nbsp;&nbsp;&nbsp;Effect of dilutive securities | 266 | 420 |
| &nbsp;&nbsp;&nbsp;&nbsp;Diluted | 105856 | 107335 |

---

See accompanying notes.

------

 **SILGAN HOLDINGS INC.**

**CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME**

For the three months ended March 31, 2026 and 2025

(Dollars in thousands)

(Unaudited)

---

| | | |
|:---|:---|:---|
| | 2026 | 2025 |
| Net income | $63039 | $67962 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other comprehensive income (loss), net of tax: |  |  |
| &nbsp;&nbsp;&nbsp; Changes in net prior service credit and actuarial losses | 1336 | 1400 |
| &nbsp;&nbsp;&nbsp; Change in fair value of derivatives | 7564 | 3071 |
| &nbsp;&nbsp; Foreign currency translation | (1553) | 45500 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other comprehensive income | 7347 | 49971 |
| &nbsp;&nbsp;&nbsp;Comprehensive income | $70386 | $117933 |

---

See accompanying notes.

------

 **SILGAN HOLDINGS INC.**

**CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS**

For the three months ended March 31, 2026 and 2025

(Dollars in thousands)

(Unaudited)

---

| | | |
|:---|:---|:---|
| | 2026 | 2025 |
| Cash flows provided by (used in) operating activities: |  |  |
| &nbsp;&nbsp;&nbsp;Net income | $63039 | $67962 |
| &nbsp;&nbsp;&nbsp;Adjustments to reconcile net income to net cash<br>&nbsp;&nbsp;&nbsp;&nbsp;provided by (used in) operating activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | 84932 | 79363 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amortization of debt discount and debt issuance costs | 1634 | 1413 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Rationalization charges | 9047 | 10959 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Stock compensation expense | 5699 | 4380 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Loss on early extinguishment of debt | 1017 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other changes that provided (used) cash: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Trade accounts receivable, net | (575596) | (404478) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Inventories | (54023) | (115166) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Trade accounts payable | (313941) | (281591) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accrued liabilities | (17839) | (33346) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other, net | (3542) | (12897) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash (used in) operating activities | (799573) | (683401) |
| Cash flows provided by (used in) investing activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Capital expenditures | (82444) | (82924) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Proceeds from asset sales | 2067 | 52 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other, net | 396 | 400 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash (used in) investing activities | (79981) | (82472) |
| Cash flows provided by (used in) financing activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Borrowings under revolving loans | 1069325 | 1110508 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Repayments under revolving loans | (162528) | (6107) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Repayment of principal amounts under finance leases | (1181) | (1348) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Repayments of long-term debt | (542500) | (706274) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Changes in outstanding checks - principally vendors | (97369) | (84971) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dividends paid on common stock | (22849) | (21939) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Debt issuance costs | (1260) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Repurchase of common stock | (7844) | (6873) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash provided by financing activities | 233794 | 282996 |
| Effect of exchange rate changes on cash and cash equivalents | 530 | 13053 |
| Cash and cash equivalents: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net (decrease) | (645230) | (469824) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Balance at beginning of year | 1080659 | 822854 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Balance at end of period | $435429 | $353030 |
| Interest paid, net | $52308 | $50594 |
| Income taxes paid, net | 7881 | 12175 |

---

See accompanying notes.

------

**SILGAN HOLDINGS INC.**

**CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY**

For the three months ended March 31, 2026 and 2025

(Dollars and shares in thousands, except per share amounts)

(Unaudited)

---

| | | |
|:---|:---|:---|
| | 2026 | 2025 |
| Common stock - shares outstanding |  |  |
| &nbsp;&nbsp;&nbsp;Balance at beginning of period | 105442 | 106795 |
| &nbsp;&nbsp;&nbsp;Net issuance of treasury stock for vested &nbsp;&nbsp;&nbsp;&nbsp;restricted stock units  | 238 | 198 |
| &nbsp;&nbsp;&nbsp;Balance at end of period | 105680 | 106993 |
| Common stock - par value |  |  |
| &nbsp;&nbsp;&nbsp;Balance at beginning and end of period | $1751 | $1751 |
| Paid-in capital |  |  |
| &nbsp;&nbsp;&nbsp;Balance at beginning of period | 384847 | 367871 |
| &nbsp;&nbsp;&nbsp;Stock compensation expense | 5699 | 4380 |
| &nbsp;&nbsp;&nbsp;Net issuance of treasury stock for vested &nbsp;&nbsp;&nbsp;&nbsp;restricted stock units | (1221) | (1044) |
| &nbsp;&nbsp;&nbsp;Balance at end of period | 389325 | 371207 |
| Retained earnings |  |  |
| &nbsp;&nbsp;&nbsp;Balance at beginning of period | 3605043 | 3402667 |
| &nbsp;&nbsp;&nbsp;Net income | 63039 | 67962 |
| &nbsp;&nbsp;&nbsp;Dividends declared on common stock | (22518) | (21677) |
| &nbsp;&nbsp;&nbsp;Balance at end of period | 3645564 | 3448952 |
| Accumulated other comprehensive loss |  |  |
| &nbsp;&nbsp;&nbsp;Balance at beginning of period | (213556) | (353357) |
| &nbsp;&nbsp;&nbsp;Other comprehensive income | 7347 | 49971 |
| &nbsp;&nbsp;&nbsp;Balance at end of period | (206209) | (303386) |
| Treasury stock |  |  |
| &nbsp;&nbsp;&nbsp;Balance at beginning of period | (1503784) | (1429351) |
| &nbsp;&nbsp;&nbsp;Net issuance of treasury stock for vested &nbsp;&nbsp;&nbsp;&nbsp;restricted stock units | (6050) | (5829) |
| &nbsp;&nbsp;&nbsp;Balance at end of period | (1509834) | (1435180) |
| Total stockholders' equity | $2320597 | $2083344 |
| Dividends declared on common stock per share | $0.21 | $0.20 |

---

See accompanying notes.

------

**SILGAN HOLDINGS INC.**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

(Information at March 31, 2026 and 2025 and for the

three months then ended is unaudited)

**Note 1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Significant Accounting Policies**

**Basis of Presentation.** The accompanying unaudited condensed consolidated financial statements of Silgan Holdings Inc., or Silgan, have been prepared in accordance with U.S. generally accepted accounting principles, or GAAP, for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, the accompanying financial statements include all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation. The results of operations for any interim period are not necessarily indicative of the results of operations for the full year.

The Condensed Consolidated Balance Sheet at December 31, 2025 has been derived from our audited consolidated financial statements at that date, but does not include all of the information and footnotes required by GAAP for complete financial statements.

You should read the accompanying condensed consolidated financial statements in conjunction with our consolidated financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2025.

**Note 2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Revenue**

The following tables present our revenues disaggregated by reportable segment and geography as they best depict how the nature, amount, timing and uncertainty of revenue and cash flows are affected by economic factors. Revenues by segment for the three months ended March 31 were as follows:

---

| | | |
|:---|:---|:---|
| | 2026 | 2025 |
| | (Dollars in thousands) | (Dollars in thousands) |
| Dispensing and Specialty Closures | $685322 | $671103 |
| Metal Containers | 724870 | 628427 |
| Custom Containers | 151066 | 167131 |
|  | $1561258 | $1466661 |

---

Revenues by geography for the three months ended March 31 were as follows:

---

| | | |
|:---|:---|:---|
| | 2026 | 2025 |
| | (Dollars in thousands) | (Dollars in thousands) |
| North America | $1083636 | $1017570 |
| Europe and other | 477622 | 449091 |
|  | $1561258 | $1466661 |

---

Our contract assets primarily consist of unbilled accounts receivable related to over time revenue recognition and were $114.0 million, $115.3 million, and $112.5 million as of March 31, 2026 and 2025 and December 31, 2025, respectively. Unbilled receivables are included in trade accounts receivable, net on our Condensed Consolidated Balance Sheets. We have entered into various supply chain financing, or SCF, arrangements with financial institutions pursuant to which we sell receivables of certain customers to such financial institutions without recourse and accelerate payment in respect of such receivables sooner than provided in the applicable supply agreements with such customers. Receivables sold under these arrangements totaled $216.1 million and $225.7 million for the three months ended March 31, 2026 and 2025, respectively.

------

**SILGAN HOLDINGS INC.**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

(Information at March 31, 2026 and 2025 and for the

three months then ended is unaudited)

**Note 3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Rationalization Charges** 

We continually evaluate cost reduction opportunities across each of our segments, including rationalizations of our existing facilities through plant closings and downsizings. We use a disciplined approach to identify opportunities that generate attractive cash returns. Rationalization charges by segment for the three months ended March 31 were as follows:

---

| | | |
|:---|:---|:---|
| | 2026 | 2025 |
| | (Dollars in thousands) | (Dollars in thousands) |
| Dispensing and Specialty Closures | $2482 | $4371 |
| Metal Containers | 5733 | 4932 |
| Custom Containers | 832 | 1656 |
|  | $9047 | $10959 |

---

Activity in reserves for our rationalization plans were as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Employee<br>Severance<br>and Benefits | Plant<br>Exit<br>Costs | Non-Cash<br>Asset<br>Write-Downs | Total |
| | (Dollars in thousands) | (Dollars in thousands) | (Dollars in thousands) | (Dollars in thousands) |
| Balance at December 31, 2025 | $44962 | $192 | $— | $45154 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Charged to expense | 3660 | 3380 | 2007 | 9047 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Utilized and currency translation | (3612) | (3572) | (2007) | (9191) |
| Balance at March 31, 2026 | $45010 | $— | $— | $45010 |

---

Non-cash asset write-downs were the result of comparing the carrying value of certain facilities and production related equipment to their fair value using estimated future discounted cash flows, a Level 3 fair value measurement (see Note 7 for information regarding a Level 3 fair value measurement).

Rationalization reserves as of March 31, 2026 were recorded in our Condensed Consolidated Balance Sheet as accrued liabilities of $21.0 million and other liabilities of $24.0 million. Excluding the impact of our withdrawal from the Central States, Southeast and Southwest Areas Pension Plan, or the Central States Pension Plan, in 2019, remaining expenses and cash expenditures for our rationalization plans are expected to be $18.1 million and $38.1 million, respectively. Remaining expenses for the accretion of interest for the withdrawal liability related to the Central States Pension Plan are expected to average approximately $0.7 million per year and be recognized annually through 2040, and remaining cash expenditures for the withdrawal liability related to the Central States Pension Plan are expected to be approximately $2.6 million annually through 2040.

------

**SILGAN HOLDINGS INC.**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

(Information at March 31, 2026 and 2025 and for the

three months then ended is unaudited)

**Note 4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Accumulated Other Comprehensive Loss**

Accumulated other comprehensive loss is reported in our Condensed Consolidated Statements of Stockholders' Equity. Amounts included in accumulated other comprehensive loss, net of tax, were as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Unrecognized Net<br>Defined Benefit<br>Plan Costs | Change in Fair<br>Value of<br>Derivatives | Foreign<br>Currency<br>Translation | Total |
| | (Dollars in thousands) | (Dollars in thousands) | (Dollars in thousands) | (Dollars in thousands) |
| Balance at December 31, 2025 | $(116840) | $(966) | $(95750) | $(213556) |
| &nbsp;&nbsp;&nbsp;Other comprehensive income before reclassifications |  | 7120 | (1553) | 5567 |
| &nbsp;&nbsp;&nbsp;Amounts reclassified from accumulated other&nbsp;&nbsp;&nbsp;&nbsp;comprehensive loss | 1336 | 444 |  | 1780 |
| &nbsp;&nbsp;&nbsp; Other comprehensive income | 1336 | 7564 | (1553) | 7347 |
| Balance at March 31, 2026 | $(115504) | $6598 | $(97303) | $(206209) |

---

The amounts reclassified to earnings from the unrecognized net defined benefit plan costs component of accumulated other comprehensive loss for the three months ended March 31, 2026 were net (losses) of $(1.6) million, excluding income tax benefits of $0.3 million. For the three months ended March 31, 2026, these net (losses) consisted primarily of amortization of net actuarial (losses) of $(1.6) million. Amortization of net actuarial losses and net prior service cost was recorded in other pension and postretirement income in our Condensed Consolidated Statements of Income. See Note 10 for further information.

The amounts reclassified to earnings from the change in fair value of derivatives component of accumulated other comprehensive loss for the three months ended March 31, 2026 were not significant.

Other comprehensive income before reclassifications related to foreign currency translation for the three months ended March 31, 2026 consisted of (i) foreign currency (losses) related to translation of quarter end financial statements of foreign subsidiaries utilizing a functional currency other than the U.S. dollar of $(25.2) million and (ii) foreign currency gains related to our net investment hedges of $31.3 million, excluding an income tax provision of $(7.6) million. See Note 7 for further discussion.

**Note 5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Inventories**

Inventories consisted of the following:

---

| | | | |
|:---|:---|:---|:---|
| | March 31, 2026 | March 31, 2025 | Dec. 31, 2025 |
| | (Dollars in thousands) | (Dollars in thousands) | (Dollars in thousands) |
| Raw materials | $483443 | $440846 | $586296 |
| Work-in-process | 259725 | 214285 | 204882 |
| Finished goods | 691396 | 651648 | 595089 |
| Other | 17179 | 17463 | 16861 |
|  | 1451743 | 1324242 | 1403128 |
| Adjustment to value inventory at cost on the LIFO method | (322994) | (268961) | (322994) |
|  | $1128749 | $1055281 | $1080134 |

---

------

**SILGAN HOLDINGS INC.**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

(Information at March 31, 2026 and 2025 and for the

three months then ended is unaudited)

**Note 6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Long-Term Debt**

Long-term debt consisted of the following:

---

| | | | |
|:---|:---|:---|:---|
| | March 31, 2026 | March 31, 2025 | Dec. 31, 2025 |
| | (Dollars in thousands) | (Dollars in thousands) | (Dollars in thousands) |
| Bank debt |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Bank revolving loans | $894685 | $1082007 | $— |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;U.S. term loans | 799000 | 850000 | 841500 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Euro term loans | 1026610 | 972180 | 1046390 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other foreign bank revolving and term loans | 51510 | 55238 | 46165 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total bank debt | 2771805 | 2959425 | 1934055 |
| 4⅛% Senior Notes | 600000 | 600000 | 600000 |
| 2¼% Senior Notes | 576100 | 540100 | 587200 |
| 4¼% Senior Notes | 691320 |  | 704640 |
| 1.4% Senior Secured Notes |  | 500000 | 500000 |
| Finance leases | 37554 | 41228 | 38783 |
| Total debt - principal | 4676779 | 4640753 | 4364678 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Less unamortized debt issuance costs and debt discount | 16332 | 12190 | 17830 |
| Total debt | 4660447 | 4628563 | 4346848 |
| &nbsp;&nbsp;&nbsp;Less current portion | 988323 | 1145091 | 631632 |
|  | $3672124 | $3483472 | $3715216 |

---

At March 31, 2026, the current portion of long-term debt consisted of $405.0 million of U.S. revolving loans, $489.7 million of Euro revolving loans and $51.8 million of Euro term loans under our amended and restated senior secured credit facility, as amended, or the Credit Agreement, $38.3 million of other foreign bank revolving and term loans and $3.5 million of finance leases.

On February 3, 2026, we prepaid $42.5 million principal amount of outstanding U.S. term loans under the Credit Agreement with cash on hand.

On March 6, 2026, we entered into the Sixth Amendment to Amended and Restated Credit Agreement, or the Sixth Amendment, with the lenders party to the Credit Agreement and Wells Fargo Bank, National Association, as administrative agent. The Sixth Amendment amended the Credit Agreement to improve the interest rate margin grid for term loans and eliminate the credit spread adjustments effective March 6, 2026 for Term SOFR Loans, Daily Simple RFR Loans and Term CORRA Loans (each as defined in the Credit Agreement). Effective with the Sixth Amendment, the margin for term loans maintained as Eurocurrency Rate Loans and RFR Loans (each as defined in the Credit Agreement) was 1.25 percent, and the margin for term loans maintained as Base Rate Loans (as defined in the Credit Agreement) was 0.25 percent. In accordance with the Sixth Amendment, the margin for term loans and revolving loans will be reset quarterly after March 31, 2026 based upon our Total Net Leverage Ratio (as defined in the Credit Agreement) as provided in the Credit Agreement. The range for the applicable margin for term loans will be 0.00 percent to 0.50 percent for Base Rate Loans and 1.00 percent to 1.50 percent for Eurocurrency Rate Loans and RFR Loans.

On March 31, 2026, we repaid all $500.0 million aggregate principal amount of our outstanding 1.4% Senior Secured Notes due 2026, or the 1.4% Notes, at 100 percent of their principal amount plus accrued and unpaid interest to the repayment date. We funded this repayment with revolving loan borrowings under the Credit Agreement and cash on hand. As a result of such redemption and satisfaction and discharge of the indenture for the 1.4% Notes (including the discharge of the guarantees therein of the 1.4% Notes by our U.S. subsidiaries that also guarantee our obligations under the Credit Agreement), the guarantees of the 4⅛% Senior Notes, the 2¼% Senior Notes and the 4¼% Senior Notes by our U.S. subsidiaries that also guarantee our obligations under the Credit Agreement were automatically released and discharged on March 31, 2026.

------

**SILGAN HOLDINGS INC.**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

(Information at March 31, 2026 and 2025 and for the

three months then ended is unaudited)

**Note 7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Financial Instruments**

The financial instruments recorded in our Condensed Consolidated Balance Sheets include cash and cash equivalents, trade accounts receivable, trade accounts payable, debt obligations and swap agreements. Due to their short-term maturity, the carrying amounts of trade accounts receivable and trade accounts payable approximate their fair market values. The following table summarizes the carrying amounts and estimated fair values of our other financial instruments at March 31, 2026:

---

| | | |
|:---|:---|:---|
| | Carrying<br>Amount | Fair<br>Value |
| | (Dollars in thousands) | (Dollars in thousands) |
| <u>Assets:</u> |  |  |
| Cash and cash equivalents | $435429 | $435429 |
| <u>Liabilities:</u> |  |  |
| Bank debt | $2771805 | $2771805 |
| 4⅛% Senior Notes | 599729 | 586686 |
| 2¼% Senior Notes | 576100 | 554715 |
| 4¼% Senior Notes | 691320 | 671569 |

---

<u>Fair Value Measurements</u>

GAAP defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (exit price). GAAP classifies the inputs used to measure fair value into a hierarchy consisting of three levels. Level 1 inputs represent unadjusted quoted prices in active markets for identical assets or liabilities. Level 2 inputs represent unadjusted quoted prices in active markets for similar assets or liabilities, or unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active, or inputs other than quoted prices that are observable for the asset or liability. Level 3 inputs represent unobservable inputs for the asset or liability. Financial assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement.

*Financial Instruments Measured at Fair Value*

The financial assets and liabilities that were measured on a recurring basis at March 31, 2026 consisted of our cash and cash equivalents and derivative instruments. We measured the fair value of cash and cash equivalents using Level 1 inputs. We measured the fair value of our derivative instruments using the income approach. The fair value of our derivative instruments reflects the estimated amounts that we would pay or receive based on the present value of the expected cash flows derived from market interest rates and prices. As such, these derivative instruments were classified within Level 2.

*Financial Instruments Not Measured at Fair Value*

Our bank debt, 4⅛% Senior Notes, 2¼% Senior Notes and 4¼% Senior Notes were recorded at historical amounts in our Condensed Consolidated Balance Sheets, as we have not elected to measure them at fair value. We measured the fair value of our variable rate bank debt using the market approach based on Level 2 inputs. Fair values of the 4⅛% Senior Notes, 2¼% Senior Notes and 4¼% Senior Notes were estimated based on quoted market prices, a Level 1 input.

------

**SILGAN HOLDINGS INC.**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

(Information at March 31, 2026 and 2025 and for the

three months then ended is unaudited)

<u>Derivative Instruments and Hedging Activities</u>

Our derivative financial instruments were recorded in the Condensed Consolidated Balance Sheets at their fair values. Changes in fair values of derivatives are recorded in each period in earnings or comprehensive income, depending on whether a derivative is designated as part of a hedge transaction and, if it is, the type of hedge transaction.

We utilize certain derivative financial instruments to manage a portion of our interest rate and natural gas cost exposures. We generally limit our use of derivative financial instruments to interest rate and natural gas swap agreements. We do not engage in trading or other speculative uses of these financial instruments. For a financial instrument to qualify as a hedge, we must be exposed to interest rate or price risk, and the financial instrument must reduce the exposure and be designated as a hedge. Financial instruments qualifying for hedge accounting must maintain a high correlation between the hedging instrument and the item being hedged, both at inception and throughout the hedged period.

We also utilize certain internal hedging strategies to minimize our foreign currency exchange rate risk. Net investment hedges that qualify for hedge accounting result in the recognition of foreign currency gains or losses, net of tax, in accumulated other comprehensive loss.

<u>Interest Rate Swap Agreements</u>

As of March 31, 2026 and December 31, 2025, we had outstanding $300 million aggregate notional principal amount of U.S. dollar interest rate swap agreements with a weighted average fixed rate of 3.90 percent and €685.0 million aggregate notional principal amount of Euro interest rate swap agreements with a weighted average fixed rate of 2.43 percent. These agreements were entered into with financial institutions which are expected to fully perform under the terms thereof. The difference between amounts to be paid or received on our interest rate swap agreements is recorded in interest and other debt expense in our Condensed Consolidated Statements of Income and was not significant for the three months ended March 31, 2026. The total fair value of our interest rate swaps agreements in effect at March 31, 2026 was not significant.

<u>Natural Gas Swap Agreements</u>

We have entered into natural gas swap agreements to manage a portion of our exposure to fluctuations in natural gas prices. The difference between amounts to be paid or received on our natural gas swap agreements is recorded in cost of goods sold in our Condensed Consolidated Statements of Income and was not significant for the three months ended March 31, 2026. These agreements are with a financial institution which is expected to fully perform under the terms thereof. The total fair value of our natural gas swap agreements in effect at March 31, 2026 was not significant.

<u>Foreign Currency Exchange Rate Risk</u>

In an effort to minimize our foreign currency exchange rate risk, we have financed acquisitions of foreign operations primarily with borrowings denominated in Euros. In addition, where available, we have borrowed funds in local currency or implemented certain internal hedging strategies to minimize our foreign currency exchange rate risk related to foreign operations, including net investment hedges related to the Euro term loans under the Credit Agreement which are Euro denominated. Foreign currency gains related to our net investment hedges included in accumulated other comprehensive loss for the three months ended March 31, 2026 were $31.3 million.

------

**SILGAN HOLDINGS INC.**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

(Information at March 31, 2026 and 2025 and for the

three months then ended is unaudited)

**Note 8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Commitments and Contingencies**

We are a party to other legal proceedings, contract disputes and claims arising in the ordinary course of our business. We are not a party to, and none of our properties are subject to, any pending legal proceedings which could have a material adverse effect on our business or financial condition.

**Note 9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Supply Chain Finance Program**

We have a supply chain finance ("SCF") program with a major global financial institution. Under this SCF program, a qualifying supplier may elect, but is not obligated, to sell its receivables from us to such financial institution. Once a qualifying supplier elects to participate in this SCF program, all of our payments to the participating supplier are paid to such financial institution in this SCF program on the invoice due date under our agreement with such supplier, regardless of whether the individual invoice was sold by the supplier to such financial institution. We may terminate our agreement with the financial institution upon at least 30 days' notice, and the financial institution may terminate our agreement upon at least 10 days' notice. Additionally, suppliers who elect to participate in this SCF program may terminate their participation upon at least 30 days' notice. The suppliers' invoices sold under this SCF program can be outstanding up to 210 days from the invoice date. Suppliers' invoices included in this SCF program were $357.6 million, $262.9 million and $438.5 million at March 31, 2026 and 2025 and December 31, 2025, respectively, and were included in accounts payable in our Condensed Consolidated Balance Sheets.

**Note 10.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Retirement Benefits** 

The components of the net periodic pension benefit cost for the three months ended March 31 were as follows:

---

| | | |
|:---|:---|:---|
| | 2026 | 2025 |
| | (Dollars in thousands) | (Dollars in thousands) |
| Service cost | $1582 | $1944 |
| Interest cost | 7681 | 8119 |
| Expected return on plan assets | (10409) | (10257) |
| Amortization of prior service (credit) cost | (13) | 8 |
| Amortization of actuarial losses | 1782 | 1893 |
| Net periodic benefit cost | $623 | $1707 |

---

The components of the net periodic other postretirement benefit (credit) cost for the three months ended March 31 were as follows:

---

| | | |
|:---|:---|:---|
| | 2026 | 2025 |
| | (Dollars in thousands) | (Dollars in thousands) |
| Service cost | $3 | $4 |
| Interest cost | 92 | 151 |
| Amortization of prior service credit | (16) | (15) |
| Amortization of actuarial gains | (157) | (86) |
| Net periodic benefit (credit) cost | $(78) | $54 |

---

------

**SILGAN HOLDINGS INC.**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

(Information at March 31, 2026 and 2025 and for the

three months then ended is unaudited)

**Note 11.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Income Taxes**

Silgan and its subsidiaries file U.S. Federal income tax returns, as well as income tax returns in various states and foreign jurisdictions. We expect the Internal Revenue Service, or IRS, will complete its review of the 2024 tax year with no change to our filed federal income tax return. We have been accepted into the Compliance Assurance Process program for the 2025 and 2026 tax years which provides for the review by the IRS of tax matters relating to our tax return prior to filing.

**Note 12.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Treasury Stock**

On November 5, 2025, our Board of Directors authorized the repurchase by us of up to an aggregate of $500.0 million of our common stock by various means from time to time through and including December 31, 2029. We did not repurchase any shares of our common stock pursuant to this authorization during the three months ended March 31, 2026. At March 31, 2026, we had $500.0 million remaining under this authorization for the repurchase of our common stock.

During the first three months of 2026, we issued 390,639 treasury shares which had an average cost of $3.13 per share for restricted stock units that vested during the period that had been previously issued under our stock-based compensation plans. In accordance with the applicable agreements for such restricted stock units, we repurchased 152,852 shares of our common stock at an average cost of $47.57 to satisfy minimum employee withholding tax requirements resulting from the vesting of such restricted stock units.

We account for treasury shares using the first-in, first-out (FIFO) cost method. As of March 31, 2026, 69,432,738 shares of our common stock were held in treasury.

**Note 13.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Stock-Based Compensation**

We currently have one stock-based compensation plan in effect under which we have issued restricted stock units to our officers, other key employees and outside directors. During the first three months of 2026, 777,600 restricted stock units were granted to certain of our officers and other key employees. The fair value of these restricted stock units at the grant date was $37.0 million, which is being amortized ratably over the respective vesting period from the grant date.

------

**SILGAN HOLDINGS INC.**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

(Information at March 31, 2026 and 2025 and for the

three months then ended is unaudited)

**Note 14.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Segment Information**

Our chief operating decision maker, who is our Chief Executive Officer and President, evaluates performance of our business segments and allocates resources based on the adjusted EBIT of our business segments. Adjusted EBIT is not a defined term under GAAP. We define adjusted EBIT as income before interest and income taxes excluding acquired intangible asset amortization expense, other pension (income) expense for U.S. pension plans and closed facilities, rationalization charges and costs attributed to announced acquisitions and including, as applicable, equity in earnings of affiliates, net of tax. Adjusted EBIT should not be considered in isolation or as a substitute for income before interest and income taxes or any other financial data prepared in accordance with GAAP and may not be comparable to calculations of similarly titled measures by other companies.

Reportable segment information was as follows:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | Dispensing and Specialty Closures | Metal<br>Containers | Custom<br>Containers | Corporate | Total |
| | (Dollars in thousands) | (Dollars in thousands) | (Dollars in thousands) | (Dollars in thousands) | (Dollars in thousands) |
| <u>Three months ended March 31, 2026</u> |  |  |  |  |  |
| Net sales | $685322 | $724870 | $151066 | $— | $1561258 |
| Segment expenses and other <sup>(a)</sup> | 590447 | 675045 | 129348 | 15667 | 1410507 |
| Equity in earnings of affiliates, net of tax | 1198 |  |  |  | 1198 |
| Adjusted EBIT | 96073 | 49825 | 21718 | (15667) | 151949 |
| Depreciation | 40668 | 19991 | 8039 | 118 | 68816 |
| Segment assets | 5756062 | 2665140 | 759653 | 62420 | 9243275 |
| Capital expenditures | 48486 | 29110 | 4848 |  | 82444 |
| <u>Three months ended March 31, 2025</u> |  |  |  |  |  |
| Net sales | $671103 | $628427 | $167131 | $— | $1466661 |
| Segment expenses and other <sup>(a)</sup> | 573062 | 578871 | 142547 | 15073 | 1309553 |
| Equity in earnings of affiliates, net of tax | 1162 |  |  |  | 1162 |
| Adjusted EBIT | 99203 | 49556 | 24584 | (15073) | 158270 |
| Depreciation | 35855 | 19285 | 8764 | 46 | 63950 |
| Segment assets | 5566505 | 2352480 | 782577 | 37677 | 8739239 |
| Capital expenditures | 43434 | 31243 | 7839 | 408 | 82924 |

---

(a)&nbsp;&nbsp;&nbsp;&nbsp;Segment expenses and other includes cost of goods sold, selling, general and administrative expenses, and other pension and postretirement (income) expense and excludes acquired intangible asset amortization expense, other pension (income) expense only for U.S. pension plans and closed facilities, and costs attributed to announced acquisitions.

------

**SILGAN HOLDINGS INC.**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

(Information at March 31, 2026 and 2025 and for the

three months then ended is unaudited)

Total adjusted EBIT is reconciled to income before income taxes for the three months ended March 31 as follows:

---

| | | |
|:---|:---|:---|
| | 2026 | 2025 |
| | (Dollars in thousands) | (Dollars in thousands) |
| Total adjusted EBIT | $151949 | $158270 |
| Less: |  |  |
| Acquired intangible asset amortization expense | 16116 | 15413 |
| Other pension (income) for U.S. pension plans and closed facilities | (1007) | (925) |
| Equity in earnings of affiliates, net of tax | 1198 | 1162 |
| Rationalization charges | 9047 | 10959 |
| Costs attributed to announced acquisitions |  | 1117 |
| &nbsp;&nbsp;Income before interest and income taxes | 126595 | 130544 |
| Interest and other debt expense | 42449 | 42928 |
| &nbsp;&nbsp;Income before income taxes | $84146 | $87616 |

---

Net sales and adjusted EBIT of our metal containers segment and of part of our dispensing and specialty closures segment are dependent, in part, upon the vegetable and fruit harvests in the United States and, to a lesser extent, in a variety of national growing regions in Europe. The size and quality of these harvests varies from year to year, depending in large part upon the weather conditions in applicable regions. Because of the seasonality of the harvests, we have historically experienced higher unit sales volume in the third quarter of our fiscal year and generated a disproportionate amount of our annual adjusted EBIT during that quarter.

------

Item 2.

**MANAGEMENT'S DISCUSSION AND ANALYSIS OF**

**<u>FINANCIAL CONDITION AND RESULTS OF OPERATIONS</u>**

Statements included in "Management's Discussion and Analysis of Financial Condition and Results of Operations" and elsewhere in this Quarterly Report on Form 10-Q that are not historical facts are "forward-looking statements" made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and Securities Exchange Act of 1934, as amended. Such forward-looking statements are made based upon management's expectations and beliefs concerning future events impacting us and therefore involve a number of uncertainties and risks, including, but not limited to, those described in our Annual Report on Form 10-K for the fiscal year ended December 31, 2025 and in our other filings with the Securities and Exchange Commission. As a result, the actual results of our operations or our financial condition could differ materially from those expressed or implied in these forward-looking statements.

***General***

We are a leading manufacturer and supplier of sustainable rigid packaging solutions for the world's essential consumer goods products. We currently produce dispensing and specialty closures for the fragrance and beauty, food, beverage, personal and health care, home care and lawn and garden markets; steel and aluminum containers for pet and human food and general line products; and custom designed plastic containers for the pet and human food, consumer health and pharmaceutical, personal care, home care, lawn and garden and automotive markets. We are a leading worldwide manufacturer of dispensing and specialty closures, a leading manufacturer of metal containers in North America and Europe, and a leading manufacturer of custom containers in North America for a variety of markets.

Our objective is to increase shareholder value by efficiently deploying capital and management resources to grow our business, reduce operating costs and build sustainable competitive positions, or franchises, and to complete acquisitions that generate attractive cash returns. We have grown our net sales and income from operations largely through acquisitions but also through internal growth, and we continue to evaluate acquisition opportunities in the consumer goods packaging market. If acquisition opportunities are not identified over a longer period of time, we may use our cash flow to repay debt, repurchase shares of our common stock or increase dividends to our stockholders or for other permitted purposes.

------

**RESULTS OF OPERATIONS**

The following table sets forth certain unaudited income statement data expressed as a percentage of net sales for the three months ended March 31:

---

| | | |
|:---|:---|:---|
| | 2026 | 2025 |
| Net sales |  |  |
| &nbsp;&nbsp;&nbsp;Dispensing and Specialty Closures | 43.9% | 45.8% |
| &nbsp;&nbsp;&nbsp;Metal Containers | 46.4 | 42.8 |
| &nbsp;&nbsp;&nbsp;Custom Containers | 9.7 | 11.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Consolidated | 100.0 | 100.0 |
| Cost of goods sold | 83.0 | 81.6 |
| &nbsp;&nbsp;Gross profit | 17.0 | 18.4 |
| Selling, general and administrative expenses | 8.4 | 8.8 |
| Rationalization charges | 0.6 | 0.7 |
| Other pension and postretirement income | (0.1) |  |
| &nbsp;&nbsp;Income before interest and income taxes | 8.1 | 8.9 |
| Interest and other debt expense | 2.7 | 3.0 |
| &nbsp;&nbsp;Income before income taxes | 5.4 | 5.9 |
| Provision for income taxes | 1.4 | 1.4 |
| Income before equity in earnings of affiliates | 4.0 | 4.5 |
| Equity in earnings of affiliates, net of tax | 0.1 | 0.1 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net income | 4.1% | 4.6% |

---

Summary unaudited results of operations for the three months ended March 31 are provided below.

---

| | | |
|:---|:---|:---|
| | 2026 | 2025 |
| | (dollars in millions) | (dollars in millions) |
| Net sales |  |  |
| &nbsp;&nbsp;&nbsp;Dispensing and Specialty Closures | $685.3 | $671.1 |
| &nbsp;&nbsp;&nbsp;Metal Containers | 724.9 | 628.4 |
| &nbsp;&nbsp;&nbsp;Custom Containers | 151.1 | 167.2 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Consolidated | $1561.3 | $1466.7 |
| Income before interest and income taxes |  |  |
| &nbsp;&nbsp;&nbsp;Dispensing and Specialty Closures | $77.3 | $79.9 |
| &nbsp;&nbsp;&nbsp;Metal Containers | 45.0 | 44.7 |
| &nbsp;&nbsp;&nbsp;Custom Containers | 19.9 | 22.1 |
| &nbsp;&nbsp;&nbsp;Corporate | (15.6) | (16.2) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Consolidated | $126.6 | $130.5 |

---

***Three Months Ended March 31, 2026 Compared with Three Months Ended March 31, 2025***

***Net Sales***. In the first quarter of 2026, consolidated net sales were $1.56 billion, an increase of $94.6 million, or 6.4 percent, as compared to the first quarter of 2025 primarily due to the contractual pass through of higher raw material and other manufacturing costs in the dispensing and specialty closures and metal containers segments, the impact from favorable foreign currency translation of approximately $47.0 million and higher unit volumes in the metal containers segment, partially offset by lower volumes in the dispensing and specialty closures and the custom containers segments and a less favorable mix of products sold in the dispensing and specialty closures and metal containers segments.

------

***Gross Profit***. Gross profit margin decreased 1.4 percentage points to 17.0 percent in the first quarter of 2026 as compared to the same period in 2025 primarily for the reasons discussed below in "Income before Interest and Income Taxes".

***Selling, General and Administrative Expenses***. In the first quarter of 2026, selling, general and administrative expenses as a percentage of consolidated net sales decreased to 8.4 percent as compared to 8.8 percent in the first quarter of 2025. For the first quarter of 2026, selling, general and administrative expenses increased $2.1 million to $131.2 million as compared to the first quarter of 2025.

***Income before Interest and Income Taxes***. In the first quarter of 2026, income before interest and income taxes decreased by $3.9 million to $126.6 million as compared to $130.5 million in the first quarter of 2025, and margins decreased to 8.1 percent from 8.9 percent over the same periods. The decrease in income before interest and income taxes was primarily the result of a less favorable mix of products sold and lower unit volumes in the dispensing and specialty closures segment, the benefit in the prior year quarter from the sell through of lower cost inventory and the adverse impact in the current year quarter from the sell through of higher cost inventory in our European metal closures operations, lower volumes in the custom containers segment and a less favorable mix of products sold in the metal containers segment, partially offset by the favorable impact of foreign currency, lower rationalization charges, higher unit volumes in the metal containers segment and lower costs attributed to announced acquisitions. Rationalization charges were $9.0 million and $11.0 million in the first quarters of 2026 and 2025, respectively. Costs attributed to announced acquisitions were $1.1 million in the first quarter of 2025.

***Interest and Other Debt Expense****.* In the first quarter of 2026, interest and other debt expense before the loss on early extinguishment of debt decreased $1.5 million to $41.4 million as compared to $42.9 million in the first quarter of 2025. The decrease was primarily due to lower weighted average interest rates during the current year period.

***Provision for Income Taxes****.* For the first quarters of 2026 and 2025, the effective tax rates were 26.5 percent and 23.8 percent, respectively. The increase in the effective tax rate in the first quarter of 2026 was primarily due to changes in the geographic mix of profit in the current year period as compared to the prior year period.

------

**Non-GAAP Measures**

Generally accepted accounting principles in the United States are commonly referred to as GAAP. A non-GAAP financial measure is generally defined as a financial measure that purports to measure financial performance, financial position or liquidity but excludes or includes amounts that could not be so adjusted in the most comparable GAAP measure. Adjusted EBIT and adjusted EBIT margin are unaudited supplemental measures of financial performance that the Company uses, which are not required by, or presented in accordance with, GAAP and therefore are non-GAAP financial measures. These non-GAAP financial measures should not be considered as alternatives to income before interest and income taxes or any other measures derived in accordance with GAAP. Such non-GAAP financial measures should not be considered in isolation or as a substitute for any financial data prepared in accordance with GAAP and may not be comparable to similarly titled measures used by other companies. The Company uses such non-GAAP financial measures because it considers them to be important and useful supplemental measures of its and its segments' financial performance which provide a more complete understanding of the Company and its segments than could be obtained absent such non-GAAP financial measures. The Company believes that it is important and useful to present these non-GAAP financial measures because they allow for a better period-over-period comparison of results by removing the impact of items that, in management's view, do not reflect the Company's or its segments' core operating performance. Management uses these non-GAAP financial measures to review and analyze the operating performance of the Company and its segments. Investors and others are urged to review and consider carefully the adjustments made by management to the most comparable GAAP financial measure to arrive at these non-GAAP financial measures.

Adjusted EBIT, a non-GAAP financial measure, means income before interest and income taxes excluding, as applicable, acquired intangible asset amortization expense, other pension (income) expense for U.S. pension plans and closed facilities, rationalization charges and costs attributed to announced acquisitions and including, as applicable, equity in earnings of affiliates, net of tax. Adjusted EBIT margin, a non-GAAP financial measure, means adjusted EBIT divided by segment net sales.

Acquired intangible asset amortization expense is a non-cash expense related to acquired operations that management believes is not indicative of the on-going performance of the acquired operations. Since the Company's U.S. pension plans are significantly over funded and have no required cash contributions for the foreseeable future based on current regulations, management views other pension (income) expense from the Company's U.S. pension plans, which excludes service costs, as not reflective of the operational performance of the Company or its segments. Additionally, other pension expense for closed facilities relate to former operations and former employees of the Company and are not indicative of the operational performance of the Company or its segments. While rationalization costs are incurred on a regular basis, management views these costs more as an investment to generate savings rather than period costs. Costs attributed to announced acquisitions consist of third party fees and expenses that are viewed by management as part of the acquisition and not indicative of the on-going cost structure of the Company. The Company's management views the operating performance of its affiliates which are joint ventures as part of the Company's operating performance and therefore believes that the Company's share of the net operating results of its affiliates which are joint ventures should be included in the Company's adjusted EBIT.

------

A reconciliation of such non-GAAP financial measures for the three months ended March 31 is provided below:

---

| | | |
|:---|:---|:---|
| | 2026 | 2025 |
| | (Dollars in millions) | (Dollars in millions) |
| **<u>Dispensing and Specialty Closures</u>** |  |  |
| Income before interest and income taxes (EBIT) | $77.3 | $79.9 |
| Acquired intangible asset amortization expense | 14.8 | 13.9 |
| Other pension expense (income) for U.S. pension plans and closed facilities | 0.3 | (0.2) |
| Equity in earnings of affiliates, net of tax | 1.2 | 1.2 |
| Rationalization charges | 2.5 | 4.4 |
| &nbsp;&nbsp;&nbsp;Adjusted EBIT | $96.1 | $99.2 |
| **<u>Metal Containers</u>** |  |  |
| Income before interest and income taxes (EBIT) | $45 | $44.7 |
| Acquired intangible asset amortization expense | 0.4 | 0.4 |
| Other pension (income) for U.S. pension plans and closed facilities | (1.3) | (0.4) |
| Rationalization charges | 5.7 | 4.9 |
| &nbsp;&nbsp;&nbsp;Adjusted EBIT | $49.8 | $49.6 |
| **<u>Custom Containers</u>** |  |  |
| Income before interest and income taxes (EBIT) | $19.9 | $22.1 |
| Acquired intangible asset amortization expense | 1.0 | 1.1 |
| Other pension (income) for U.S. pension plans and closed facilities |  | (0.3) |
| Rationalization charges | 0.8 | 1.7 |
| &nbsp;&nbsp;&nbsp;Adjusted EBIT | $21.7 | $24.6 |
| **<u>Corporate</u>** |  |  |
| Loss before interest and income taxes (EBIT) | $(15.6) | $(16.2) |
| Costs attributed to announced acquisitions |  | 1.1 |
| &nbsp;&nbsp;&nbsp;Adjusted EBIT | $(15.6) | $(15.1) |
| Total adjusted EBIT | $152.0 | $158.3 |

---

------

**Dispensing and Specialty Closures Segment**

---

| | | |
|:---|:---|:---|
| | 2026 | 2025 |
| | (Dollars in millions) | (Dollars in millions) |
| Net sales | $685.3 | $671.1 |
| Income before interest and income taxes (EBIT) | 77.3 | 79.9 |
| Income before interest and income taxes margin (EBIT margin) | 11.3% | 11.9% |
| Adjusted EBIT | $96.1 | $99.2 |
| Adjusted EBIT margin | 14.0% | 14.8% |

---

In the first quarter of 2026, net sales for the dispensing and specialty closures segment increased $14.2 million, or 2.1 percent, as compared to the first quarter of 2025. This increase was primarily the result of the impact of favorable foreign currency translation of approximately $37.0 million and the contractual pass through of higher raw material and other costs, partially offset by lower unit volumes of three percent and a less favorable mix of products sold. Volumes and mix of products sold in the quarter were affected in part by production impacts from severe weather in the first quarter.

In the first quarter of 2026, adjusted EBIT of the dispensing and specialty closures segment decreased $3.1 million as compared to the first quarter of 2025, and adjusted EBIT margin decreased to 14.0 percent from 14.8 percent over the same periods. The decrease in adjusted EBIT was primarily due to a less favorable mix of products sold, lower volumes, the benefit in the prior year quarter from the sell through of lower cost inventory and the adverse impact in the current year quarter from the sell through of higher cost inventory in our European metal closures operations, partially offset by the favorable impact of foreign currency.

**Metal Containers Segment**

---

| | | |
|:---|:---|:---|
| | 2026 | 2025 |
| | (Dollars in millions) | (Dollars in millions) |
| Net sales | $724.9 | $628.4 |
| Income before interest and income taxes (EBIT) | 45.0 | 44.7 |
| Income before interest and income taxes margin (EBIT margin) | 6.2% | 7.1% |
| Adjusted EBIT | $49.8 | $49.6 |
| Adjusted EBIT margin | 6.9% | 7.9% |

---

In the first quarter of 2026, net sales for the metal containers segment increased $96.5 million, or 15.4 percent, as compared to the first quarter of 2025. This increase was primarily the result of the contractual pass through of higher raw material and other manufacturing costs, higher unit volumes of approximately two percent and the impact of favorable foreign currency translation of approximately $9.0 million, partially offset by a less favorable mix of products sold. The increase in unit volumes was primarily due to higher volumes for pet food markets, which was partially offset by lower volumes for fruit and vegetable markets as a result of prebuy activity in the fourth quarter of 2025.

In the first quarter of 2026, adjusted EBIT of the metal containers segment increased $0.2 million as compared to the first quarter of 2025, while adjusted EBIT margin decreased to 6.9 percent from 7.9 percent for the same periods. The increase in adjusted EBIT was primarily due to higher unit volumes, partially offset by a less favorable mix of products sold.

------

**Custom Containers Segment**

---

| | | |
|:---|:---|:---|
| | 2026 | 2025 |
| | (Dollars in millions) | (Dollars in millions) |
| Net sales | $151.1 | $167.2 |
| Income before interest and income taxes (EBIT) | 19.9 | 22.1 |
| Income before interest and income taxes margin (EBIT margin) | 13.2% | 13.2% |
| Adjusted EBIT | $21.7 | $24.6 |
| Adjusted EBIT margin | 14.4% | 14.7% |

---

In the first quarter of 2026, net sales for the custom containers segment decreased $16.1 million, or 9.6 percent, as compared to the first quarter of 2025. This decrease was principally due to lower volumes of approximately eleven percent primarily from the exit of lower margin business in 2025 as a result of footprint optimization plans to achieve previously announced cost reduction goals and customer destocking activities in the current year quarter, partially offset by the impact of favorable foreign currency translation of approximately $1.0 million.

In the first quarter of 2026, adjusted EBIT of the custom containers segment decreased $2.9 million as compared to the first quarter of 2025, and adjusted EBIT margin decreased to 14.4 percent from 14.7 percent over the same periods. The decrease in adjusted EBIT was primarily attributable to lower volumes.

**CAPITAL RESOURCES AND LIQUIDITY**

Our principal sources of liquidity have been net cash from operating activities and borrowings under our debt instruments, including our senior secured credit facility. Our liquidity requirements arise from our obligations under the indebtedness incurred in connection with our acquisitions and the refinancing of that indebtedness, capital investment in new and existing equipment, the funding of our seasonal working capital needs and other general corporate uses.

On February 3, 2026, we prepaid $42.5 million principal amount of outstanding U.S. term loans under the Credit Agreement with cash on hand.

On March 6, 2026, we entered into the Sixth Amendment, with the lenders party to the Credit Agreement and Wells Fargo Bank, National Association, as administrative agent. The Sixth Amendment amended the Credit Agreement to improve the interest rate margin grid for term loans and eliminate the credit spread adjustments effective March 6, 2026 for Term SOFR Loans, Daily Simple RFR Loans and Term CORRA Loans (each as defined in the Credit Agreement). Effective with the Sixth Amendment, the margin for term loans maintained as Eurocurrency Rate Loans and RFR Loans (each as defined in the Credit Agreement) was 1.25 percent, and the margin for term loans maintained as Base Rate Loans (as defined in the Credit Agreement) was 0.25 percent. In accordance with the Sixth Amendment, the margin for term loans and revolving loans will be reset quarterly after March 31, 2026 based upon our Total Net Leverage Ratio (as defined in the Credit Agreement) as provided in the Credit Agreement. The range for the applicable margin for term loans will be 0.00 percent to 0.50 percent for Base Rate Loans and 1.00 percent to 1.50 percent for Eurocurrency Rate Loans and RFR Loans.

On March 31, 2026, we repaid all $500.0 million aggregate principal amount of our outstanding 1.4% Notes at 100 percent of their principal amount plus accrued and unpaid interest to the repayment date. We funded this repayment with revolving loan borrowings under the Credit Agreement and cash on hand. As a result of such redemption and satisfaction and discharge of the indenture for the 1.4% Notes (including the discharge of the guarantees therein of the 1.4% Notes by our U.S. subsidiaries that also guarantee our obligations under the Credit Agreement), the guarantees of the 4⅛% Senior Notes, the 2¼% Senior Notes and the 4¼% Senior Notes by our U.S. subsidiaries that also guarantee our obligations under the Credit Agreement were automatically released and discharged on March 31, 2026.

For the three months ended March 31, 2026, we used net borrowings of revolving loans of $906.8 million, cash and cash equivalents of $645.2 million and the positive effect of exchange rate changes on cash and cash equivalents of $0.5 million to fund cash used in operations of $799.6 million, the repayment of long-term debt of $542.5 million, decreases in outstanding checks of $97.4 million, net capital expenditures and other investing activities of $80.0 million, dividends paid on our common stock of $22.8 million, repurchases of our common stock of $7.8 million, debt issuance costs of $1.2 million and the repayment of principal amounts under finance leases of $1.2 million.

------

For the three months ended March 31, 2025, we used net borrowings of revolving loans of $1.1 billion, cash and cash equivalents of $469.9 million and the positive effect of exchange rate changes on cash and cash equivalents of $13.0 million to fund the repayment of long-term debt of $706.3 million, cash used in operations of $683.4 million, decreases in outstanding checks of $85.0 million, net capital expenditures and other investing activities of $82.5 million, dividends paid on our common stock of $21.9 million, repurchases of our common stock of $6.9 million and the repayment of principal amounts under finance leases of $1.3 million.

At March 31, 2026, we had $894.7 million of revolving loans outstanding under the Credit Agreement. After taking into account outstanding letters of credit, the available portion of revolving loans under the Credit Agreement at March 31, 2026 was $583.6 million.

Because we sell metal containers and closures used in fruit and vegetable pack processing, we have seasonal sales. As is common in the industry, we must utilize working capital to build inventory and then carry accounts receivable for some customers beyond the end of the packing season. Due to our seasonal requirements, which generally peak sometime in the summer or early fall, we may incur short-term indebtedness to finance our working capital requirements. Our peak seasonal working capital requirements have historically averaged approximately $600 million. We fund seasonal working capital requirements through revolving loans under the Credit Agreement, other foreign bank loans and cash on hand. We may use the available portion of revolving loans under the Credit Agreement, after taking into account our seasonal needs and outstanding letters of credit, for other general corporate purposes including acquisitions, capital expenditures, dividends, stock repurchases and to refinance or repurchase other debt.

We believe that cash generated from operations and funds from borrowings available under the Credit Agreement and other foreign bank loans will be sufficient to meet our expected operating needs, planned capital expenditures, debt service, tax obligations, pension benefit plan contributions, share repurchases and common stock dividends for the foreseeable future. We continue to evaluate acquisition opportunities in the consumer goods packaging market and may incur additional indebtedness, including indebtedness under the Credit Agreement, to finance any such acquisition.

We are in compliance with all financial and operating covenants contained in our financing agreements and believe that we will continue to be in compliance during 2026 with all of these covenants.

***Supply Chain Finance Program***

For our suppliers, we believe that we negotiate the best terms possible, including payment terms. In connection therewith, we initiated a SCF program with a major global financial institution. Under this SCF program, a qualifying supplier may elect, but is not obligated, to sell its receivables from us to such financial institution. A participating supplier negotiates its receivables sale arrangements directly with the financial institution under this SCF program. While we are not party to, and do not participate in the negotiation of, such arrangements, such financial institution allows a participating supplier to utilize our creditworthiness in establishing a credit spread in respect of the sale of its receivables from us as well as other applicable terms. This may provide a supplier with more favorable terms than it would be able to secure on its own. We have no economic interest in a supplier's decision to sell a receivable. Once a qualifying supplier elects to participate in this SCF program and reaches an agreement with the financial institution, the supplier independently elects which individual invoices to us that they sell to the financial institution. All of our payments to a participating supplier are paid to the financial institution on the invoice due date under our agreement with such supplier, regardless of whether the individual invoice was sold by the supplier to the financial institution. The financial institution then pays the supplier on the invoice due date under our agreement with such supplier for any invoices not previously sold by the supplier to the financial institution. Amounts due to a supplier that elects to participate in this SCF program are included in accounts payable in our Condensed Consolidated Balance Sheet, and the associated payments are reflected in net cash provided by operating activities in our Condensed Consolidated Statements of Cash Flows. Separate from this SCF program, we and suppliers who participate in this SCF program generally maintain the contractual right to require the other party to negotiate in good faith the existing payment terms as a result of changes in market conditions, including changes in interest rates and general market liquidity, or in some cases for any reason. Outstanding trade accounts payables subject to this SCF program were approximately $357.6 million, $262.9 million and $438.5 million at March 31, 2026 and 2025 and December 31, 2025, respectively.

------

***Rationalization Charges***

We continually evaluate cost reduction opportunities across each of our segments, including rationalizations of our existing facilities through plant closings and downsizings. We use a disciplined approach to identify opportunities that generate attractive cash returns. Under our rationalization plans, we made cash payments of $7.2 million and $3.5 million for the three months ended March 31, 2026 and 2025, respectively. Excluding the impact of our withdrawal from the Central States Pension Plan in 2019, remaining expenses and cash expenditures for our rationalization plans are expected to be $18.1 million and $38.1 million, respectively. Remaining expenses for the accretion of interest for the withdrawal liability related to the Central States Pension Plan are expected to average approximately $0.7 million per year and be recognized annually through 2040, and remaining cash expenditures for the withdrawal liability related to the Central States Pension Plan are expected to be approximately $2.6 million annually through 2040.

You should also read Note 3 to our Condensed Consolidated Financial Statements for the three months ended March 31, 2026 included elsewhere in this Quarterly Report.

------

Item 3. **<u>QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</u>**

Market risks relating to our operations result primarily from changes in interest rates and, with respect to our international operations, in foreign currency exchange rates. In the normal course of business, we also have risk related to commodity price changes for items such as natural gas. We employ established policies and procedures to manage our exposure to these risks. Interest rate, foreign currency and commodity pricing transactions are used only to the extent considered necessary to meet our objectives. We do not utilize derivative financial instruments for trading or other speculative purposes.

Information regarding our interest rate risk, foreign currency exchange rate risk and commodity pricing risk has been disclosed in our Annual Report on Form 10-K for the fiscal year ended December 31, 2025. Since such filing, other than the changes discussed in Notes 6 and 7 to our Condensed Consolidated Financial Statements for the three months ended March 31, 2026 included elsewhere in this Quarterly Report, there has not been a material change to our interest rate risk, foreign currency exchange rate risk or commodity pricing risk or to our policies and procedures to manage our exposure to these risks.

Item 4. **<u>CONTROLS AND PROCEDURES</u>**

As required by Rule 13a-15(e) of the Securities Exchange Act of 1934, as amended, or the Exchange Act, we carried out an evaluation, under the supervision and with the participation of management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of our disclosure controls and procedures. Based upon that evaluation, as of the end of the period covered by this Quarterly Report, our Chief Executive Officer and Chief Financial Officer concluded that the disclosure controls and procedures were effective to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the Securities and Exchange Commission's rules and forms, and that our disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by us in the reports we file or submit under the Exchange Act is accumulated and communicated to our management, including the Principal Executive Officer and the Principal Financial Officer, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

There were no changes in our internal controls over financial reporting during the period covered by this Quarterly Report that have materially affected, or are reasonably likely to materially affect, these internal controls.

------

Part II. Other Information

Item 5. Other Information

In the first quarter of 2026, none of our directors or officers adopted or terminated any contract, instruction or written plan for the purchase or sale of our securities intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) or any "non-Rule 10b5-1 trading arrangement" as defined in Item 408(c) of Regulation S-K.

Item 6. Exhibits

---

| | |
|:---|:---|
| <u>Exhibit Number</u> | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Description</u> |
| \*10.1 | <u>[Sixth Amendment to Amended and Restated Credit Agreement, dated as of March 6, 2026, among Silgan Holdings Inc., Silgan Containers LLC, Silgan Plastics LLC, Silgan Containers Manufacturing Corporation, Silgan International Holdings B.V., Silgan Dispensing Systems Holdings Company, the other Guarantors party thereto, the Lenders party thereto and Wells Fargo Bank, National Association, as Administrative Agent.](exhibit1013-31x2026.htm)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp; \*+10.2 | <u>[Officer Agreement, dated November 6, 2025, between Silgan Holdings Inc. and Alexander G. Hutter.](exhibit1023-31x2026.htm)</u> |
| \*31.1 | <u>[Certification by the Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act.](exhibit3113-31x2026.htm)</u> |
| \*31.2 | <u>[Certification by the Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act.](exhibit3123-31x2026.htm)</u> |
| \*32.1 | <u>[Certification by the Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act.](exhibit3213-31x2026.htm)</u> |
| \*32.2 | <u>[Certification by the Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act.](exhibit3223-31x2026.htm)</u> |
| 101.INS | XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. |
| 101.SCH | Inline XBRL Taxonomy Extension Schema Document. |
| 101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document. |
| 101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document. |
| 101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document. |
| 101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document. |
| 104 | Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101). |

---

___________________

\*Filed herewith.

+ Management contract or compensatory plan or arrangement.

------

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Quarterly Report to be signed on its behalf by the undersigned thereunto duly authorized.

---

| | |
|:---|:---|
| | SILGAN HOLDINGS INC. |
| Dated: May 6, 2026 | /s/ Shawn C. Fabry&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; |
| | Shawn C. Fabry |
| | Executive Vice President and |
| | Chief Financial Officer |
| | (Principal Financial Officer) |

---

## Exhibit 10.1

**Exhibit 10.1**

**Execution Version**

**SIXTH AMENDMENT TO AMENDED AND RESTATED CREDIT AGREEMENT**

SIXTH AMENDMENT TO AMENDED AND RESTATED CREDIT AGREEMENT (this "<u>Amendment</u>"), dated as of March 6, 2026, among SILGAN HOLDINGS INC., a Delaware corporation ("<u>Silgan</u>"), SILGAN CONTAINERS LLC, a Delaware limited liability company ("<u>Containers</u>"), SILGAN PLASTICS LLC, a Delaware limited liability company ("<u>Plastics</u>"), SILGAN CONTAINERS MANUFACTURING CORPORATION, a Delaware corporation ("<u>Manufacturing</u>"), SILGAN INTERNATIONAL HOLDINGS B.V., a private company with limited liability incorporated under the laws of The Netherlands ("<u>Silgan International B.V.</u>"), SILGAN DISPENSING SYSTEMS HOLDINGS COMPANY, a Delaware corporation ("<u>Dispensing</u>", and together with Silgan, Containers, Plastics, Manufacturing and Silgan International B.V., the "<u>Borrowers</u>" and each individually, "<u>Borrower</u>"), the Guarantors (as defined in the Credit Agreement referred to below) party hereto, the Lenders (as defined below) and WELLS FARGO BANK, NATIONAL ASSOCIATION, as administrative agent (the "<u>Administrative Agent</u>"). Unless otherwise indicated, all capitalized terms used herein and not otherwise defined herein shall have the respective meanings provided such terms in the Credit Agreement (after giving effect to this Amendment, the "<u>Amended Credit Agreement</u>") referred to below.

W I T N E S S E T H:

WHEREAS, the Borrowers, the lenders party thereto (collectively, the "<u>Existing Lenders</u>" and, together with any financial institution party hereto that is assigning its Commitments and Loans pursuant to this Amendment and that is identified on its signature page as a "Departing Lender" (each, a "<u>Departing Lender</u>"), the "<u>Lenders</u>"), the Administrative Agent and the other parties thereto have entered into that certain Amended and Restated Credit Agreement, dated as of March 24, 2017 (as amended prior to the date hereof, the "<u>Credit Agreement</u>");

WHEREAS, the Borrowers have requested, and subject to the terms and conditions set forth herein, the Administrative Agent and the Lenders have agreed, to certain modifications of the Credit Agreement as set forth herein; and

WHEREAS, each Departing Lender has agreed to no longer continue as a Lender; and

NOW, THEREFORE, in consideration of the foregoing and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, it is agreed as follows:

SECTION 1.&nbsp;&nbsp;&nbsp;&nbsp;<u>Amendments to Credit Documents</u>. As of the Sixth Amendment Effective Date (as defined below) and, subject to and in accordance with the terms and conditions set forth herein, the Credit Agreement is hereby amended as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;<u>Section 1.01</u> of the Credit Agreement is hereby amended by:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;&nbsp;&nbsp;&nbsp;inserting the following new definition in appropriate alphabetical order:

"<u>Sixth Amendment Effective Date</u>" means March 6, 2026.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)&nbsp;&nbsp;&nbsp;&nbsp;amending (A) the pricing grid set forth in clause (i) of the definition of "Applicable Commitment Commission Percentage" and "Applicable Margin" and (B) the paragraph immediately following such pricing grid by replacing such pricing grid and paragraph in their entirety with the following:

217041600_5

------

---

| | | |
|:---|:---|:---|
| Total Net Leverage Ratio | US A Term Loans <br>maintained as Base Rate Loans | US A Term Loans and Euro A-3 Term Loans<br>maintained as<br>Eurocurrency Rate Loans or RFR Loans  |
| ≥4.25x | 0.50% | 1.50% |
| ≥3.50x and <4.25x | 0.25% | 1.25% |
| <3.50x | 0.00% | 1.00% |

---

; <u>provided</u>, <u>however</u>, that if Silgan fails to deliver the financial statements required to be delivered pursuant to <u>Section 8.01(a)</u> or <u>(b)</u> (accompanied by the officer's certificate required to be delivered pursuant to <u>Section 8.01(d)</u> showing the applicable Total Net Leverage Ratio on the relevant Test Date) on or prior to the respective date required by such Sections, then the Total Net Leverage Ratio shall be deemed to be greater than 4.25:1.00 until such time, if any, as the financial statements required as set forth above and the accompanying officer's certificate have been delivered showing the Total Net Leverage Ratio for the respective Margin Reduction Period is less than or equal to 4.25:1.00 (it being understood that, in the case of any late delivery of the financial statements and officer's certificate as so required, any reduction in the Applicable Margin shall apply only from and after the date of the delivery of the complying financial statements and officer's certificate); <u>provided</u> <u>further</u>, that the Applicable Margin shall be the respective percentage applicable to a Total Net Leverage Ratio of higher than 4.25:1.00 at all times when a Specified Default or an Event of Default is in existence. Notwithstanding anything to the contrary contained in the immediately preceding sentence (other than the further proviso thereof), (A) for the period from the Sixth Amendment Effective Date through, but not including, the Start Date in respect of Silgan's fiscal quarter ending March 31, 2026, the Applicable Margin for (x) US A Term Loans and Euro A-3 Term Loans that are maintained as Eurocurrency Rate Loans shall not be less than 1.25% and (y) US A Term Loans that are maintained as Base Rate Loans shall be not less than 0.25%, (B) with respect to each Tranche of Incremental Term Loans (to the extent then outstanding), the Applicable Margin shall be that percentage set forth in, or calculated in accordance with, <u>Section 2.14</u> and the relevant Incremental Term Loan Commitment Agreement and (C) the Applicable Margin in respect of any Tranche of Extended Term Loans shall be the applicable percentages per annum set forth in the relevant Extension Offer.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)&nbsp;&nbsp;&nbsp;&nbsp;amending the definition of "Spread Adjusted SOFR" by replacing such definition in its entirety with the following

"<u>Spread Adjusted SOFR</u>" shall mean with respect to any RFR Business Day, a rate per annum equal to the sum of (a) SOFR for such RFR Business Day <u>plus</u> (b) 0%.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv)&nbsp;&nbsp;&nbsp;&nbsp;amending the definition of "Spread Adjusted Term SOFR" by replacing such definition in its entirety with the following

"<u>Spread Adjusted Term SOFR</u>" shall mean (a) in the case of Interest Periods of one month, three months or six months, a rate per annum equal to the sum of (i) Term SOFR and (ii) 0% and (b) in the case of Interest Periods of one week or two weeks, a rate per annum equal to the sum of (i) Term SOFR, determined based on a one-month Interest Period, and (ii) 0%.

217041600_5

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(v)&nbsp;&nbsp;&nbsp;&nbsp;amending the definition of "Term CORRA Adjustment" by replacing such definition in its entirety with the following

"<u>Term CORRA Adjustment</u>" shall mean, with respect to any Term CORRA Loan, 0%.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;<u>Schedule IX</u> of the Credit Agreement is hereby amended by replacing the address of the Borrowers with the following:

Silgan Holdings Inc.

601 Merritt 7, Floor 1

Norwalk, CT 06851

Attention of: Shawn C. Fabry, EVP & Chief Financial Officer

Telephone No.: (203) 406-3184<br> Facsimile No.: (203) 975-4598<br> E-mail: sfabry@silgan.com

SECTION 2.&nbsp;&nbsp;&nbsp;&nbsp;<u>Acknowledgement and Confirmation</u>. Each of the Credit Parties party hereto hereby agrees that with respect to each Credit Document to which it is a party, after giving effect to the Amendment and the transactions contemplated hereunder:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;all of its obligations, liabilities and indebtedness under such Credit Document, including guarantee obligations, shall, except as expressly set forth herein or in the Amended Credit Agreement, remain in full force and effect on a continuous basis; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;all of the Liens and security interests created and arising under such Credit Document remain in full force and effect on a continuous basis, and the perfected status and priority to the extent provided for in <u>Section 7.05</u> of the Amended Credit Agreement of each such Lien and security interest continues in full force and effect on a continuous basis, unimpaired, uninterrupted and undischarged as collateral security for the Obligations, to the extent provided in such Credit Documents.

SECTION 3.&nbsp;&nbsp;&nbsp;&nbsp;<u>Conditions of Effectiveness of this Amendment</u>. This Amendment shall become effective on the date when the following conditions shall have been satisfied or waived (such date, the "<u>Sixth Amendment Effective Date</u>"):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;The Administrative Agent's receipt of this Amendment, duly executed by the Borrowers, the Guarantors existing as of the Sixth Amendment Effective Date, the Administrative Agent and the Lenders (including each Departing Lender);

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;Payment of all fees and expenses of the Administrative Agent and Wells Fargo Securities, LLC, and in the case of expenses, to the extent invoiced at least three (3) Business Days prior to the Sixth Amendment Effective Date (except as otherwise reasonably agreed to by Silgan), required to be paid on the Sixth Amendment Effective Date;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;&nbsp;&nbsp;&nbsp;Payment of all fees to the Lenders required to be paid on the Sixth Amendment Effective Date, including all unpaid Commitment Commissions accrued through the Sixth Amendment Effective Date; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;&nbsp;&nbsp;&nbsp;At least five (5) days prior to the Sixth Amendment Effective Date, (i) the Administrative Agent and the Lenders shall have received all documentation and other information required by regulatory

217041600_5

------

authorities under applicable Anti-Money Laundering Laws (including without limitation, any applicable "know your customer" rules and regulations and the Patriot Act) (to the extent requested by the Administrative Agent or such Lender at least ten (10 days prior to the Sixth Amendment Effective Date) and (ii) each Borrower that qualifies as a "legal entity customer" under the Beneficial Ownership Regulation shall have delivered to the Administrative Agent and any Lender requesting the same, a Beneficial Ownership Certification in relation to such Borrower (to the extent requested by the Administrative Agent or such Lender at least ten (10) days prior to the Sixth Amendment Effective Date).

For purposes of determining compliance with the conditions specified in this <u>Section 3</u>, each Lender that has signed this Amendment shall be deemed to have consented to, approved or accepted or to be satisfied with, each document or other matter required thereunder to be consented to or approved by or acceptable or satisfactory to a Lender unless the Administrative Agent shall have received notice from such Lender prior to the proposed Sixth Amendment Effective Date specifying its objection thereto.

SECTION 4.&nbsp;&nbsp;&nbsp;&nbsp;<u>Loan and Commitment Adjustments/Departing Lenders</u>. Notwithstanding anything to the contrary in the Credit Agreement, each party hereto agrees that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;<u>Loan and Commitment Adjustments</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;&nbsp;&nbsp;&nbsp;On and as of the Sixth Amendment Effective Date, each Lender agrees that (A) the aggregate principal amount of its respective (1) US A-1 Term Loans, (2) US A-2 Term Loans and (3) EUR A-3 Term Loans and (B) its respective Revolving Loan Commitment shall be as set forth opposite such Lender's name on <u>Annex A</u> attached hereto.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)&nbsp;&nbsp;&nbsp;&nbsp;On and as of the Sixth Amendment Effective Date, the requisite assignments, payments and prepayments shall be deemed to be made in such amounts among the Lenders, including the Departing Lenders, as necessary, such that after giving effect thereto, the aggregate principal amount of the US A-1 Term Loans, the US A-2 Term Loans, the EUR A-3 Term Loans and the Revolving Loan Commitment of each Lender shall be as set forth opposite such Lender's name on <u>Annex A</u> attached hereto (collectively, the "<u>Loan/Commitment Adjustments</u>") (it being understood and agreed that any outstanding Revolving Loans (as defined in the Existing Credit Agreement) and any participations in outstanding Letters of Credit and Swingline Loans shall be reallocated under the revolving loan facility in a manner such that each Lender (after giving effect to the Loan/Commitment Adjustments) holds such Revolving Loans and such participations on a ratable basis consistent with the amount of their respective Revolving Loan Commitments after giving effect to the Loan/Commitment Adjustments). In connection therewith, each party hereto agrees that (A) solely with respect to any assignments required or desired to effectuate the purposes set forth in this Sixth Amendment, such assignments shall be deemed to be made in requisite amounts among the Lenders and from each Lender to each other Lender, with the same force and effect as if such assignments were evidenced by any applicable Assignment and Assumption Agreement under the Credit Agreement and (B) the Administrative Agent is hereby authorized to mark the Register to reflect the reallocation and assignments constituting the Loan/Commitment Adjustments. Notwithstanding anything to the contrary in <u>Section 12.04</u> of the Credit Agreement or this Sixth Amendment, (1) no other documents or instruments, including any Assignment and Assumption Agreement, shall be required to be executed in connection with these assignments (all of which requirements are hereby waived), (2) no fees shall be required to be paid to the Administrative Agent in connection with such assignments, and (3) such assignments shall be deemed to be made with all applicable representations, warranties and covenants as if evidenced by an Assignment and Assumption Agreement.

217041600_5

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)&nbsp;&nbsp;&nbsp;&nbsp;In connection with the Loan/Commitment Adjustments, each Lender, as applicable, shall make such payments in Dollars to the Administrative Agent, on the Sixth Amendment Effective Date, as necessary (in the reasonable determination of the Administrative Agent) to effect the purchases of US A-1 Term Loans, the US A-2 Term Loans, the EUR A-3 Term Loans and the Revolving Loan Commitment pursuant to the Loan/Commitment Adjustments.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv)&nbsp;&nbsp;&nbsp;&nbsp;From and after the Sixth Amendment Effective Date, the Administrative Agent shall (to the extent received from the Borrowers) make payment in respect of accrued fees and interest on (A) the US A-1 Term Loans, the US A-2 Term Loans, the EUR A-3 Term Loans and the Revolving Loan Commitment that are reallocated pursuant to the Loan/Commitment Adjustments, to the extent accrued prior to the Sixth Amendment Effective Date, to the holder of such US A-1 Term Loans, US A-2 Term Loans, EUR A-3 Term Loans and Revolving Loan Commitments immediately prior to the Loan/Commitment Adjustments (including, as applicable, the Departing Lenders) and (B) the US A-1 Term Loans, the US A-2 Term Loans, the EUR A-3 Term Loans and the Revolving Loan Commitment that are reallocated pursuant to the Loan/Commitment Adjustments, to the extent accrued on or after the Sixth Amendment Effective Date, to the holder of such US A-1 Term Loans, US A-2 Term Loans, EUR A-3 Term Loans and Revolving Loan Commitments after giving effect to the Loan/Commitment Adjustments.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;<u>Departing Lenders</u>. On and as of the Sixth Amendment Effective Date and after giving effect to this Sixth Amendment, including, without limitation, the Commitment/Loan Adjustments and the payments by the Lenders pursuant to <u>Section 4(a)</u>:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;&nbsp;&nbsp;&nbsp;(A) the outstanding US A-1 Term Loan of each Departing Lender shall be $0, (B) the outstanding US A-2 Term Loan of each Departing Lender shall be $0, (C) the outstanding EUR A-3 Term Loan of each Departing Lender shall be $0 and (D) the Revolving Loan Commitment of each Departing Lender shall be $0;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)&nbsp;&nbsp;&nbsp;&nbsp;each Departing Lender shall cease to be a Lender and a Revolving Lender (as defined in the Existing Credit Agreement) under the Credit Agreement and the other Credit Documents and shall have no further rights or obligations as a Lender or a Revolving Lender under the Credit Agreement and the other Credit Documents, except to the extent of rights and obligations that survive a Lender's assignment of its commitments pursuant to <u>Section 12.04</u> of the Credit Agreement and its rights to payment of interest and fees that have accrued but not been paid on the Sixth Amendment Effective Date; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)&nbsp;&nbsp;&nbsp;&nbsp;each Departing Lender is a party to this Sixth Amendment solely for the purpose of evidencing its agreement to this <u>Section 4</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;&nbsp;&nbsp;&nbsp;<u>Waivers</u>. The Lenders party hereto (including the Departing Lenders) agree to waive (i) any notice of prepayment required under the Credit Agreement in connection with the Commitment/Loan Adjustments and (ii) any costs required to be paid pursuant to <u>Section 2.11</u> of the Credit Agreement in connection with the Commitment/Loan Adjustments.

SECTION 5.&nbsp;&nbsp;&nbsp;&nbsp;<u>Costs and Expenses</u>. Each Borrower hereby reconfirms its obligations pursuant to <u>Section 12.01</u> of the Amended Credit Agreement to pay and reimburse the Administrative Agent in accordance with the terms thereof.

SECTION 6.&nbsp;&nbsp;&nbsp;&nbsp;<u>Representations and Warranties</u>. To induce the Administrative Agent and the Lenders to enter into this Amendment, each Credit Party represents and warrants to the Administrative Agent and the other Lenders on and as of the Sixth Amendment Effective Date that, in each case:

217041600_5

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;the representations and warranties of each Credit Party set forth in <u>Article VII</u> of the Amended Credit Agreement and in each other Credit Document are true and correct in all material respects on and as of the Sixth Amendment Effective Date with the same effect as though made on and as of such date, except to the extent such representations and warranties expressly relate to an earlier date, in which case they shall be true and correct in all material respects as of such earlier date; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;prior to and immediately after effectiveness of this Amendment, no Default or Event of Default exists and is continuing.

SECTION 7.&nbsp;&nbsp;&nbsp;&nbsp;<u>Reference to and Effect on the Credit Agreement and the Credit Documents</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;On and after the Sixth Amendment Effective Date, each reference in the Credit Agreement to "this Agreement," "herein," "hereto", "hereof" and "hereunder" or words of like import referring to the Credit Agreement, and each reference in the Notes and each of the other Credit Documents to "the Credit Agreement", "thereunder", "thereof" or words of like import referring to the Credit Agreement, shall mean and be a reference to the Amended Credit Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;The Credit Agreement and each of the other Credit Documents, as specifically amended by this Amendment, are and shall continue to be in full force and effect and are hereby in all respects ratified and confirmed.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;&nbsp;&nbsp;&nbsp;The execution, delivery and effectiveness of this Amendment shall not, except as expressly provided herein, operate as a waiver of any right, power or remedy of any Lender or the Administrative Agent under any of the Credit Documents, nor constitute a waiver of any provision of any of the Credit Documents. Without limiting the generality of the foregoing, the Collateral Documents in effect immediately prior to the date hereof and all of the Collateral described therein in existence immediately prior to the date hereof do and shall continue to secure the payment of all Obligations of the Credit Parties under the Credit Documents, in each case, as amended by this Amendment.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;&nbsp;&nbsp;&nbsp;This Amendment shall constitute a "Credit Document" under and as defined in the Amended Credit Agreement.

SECTION 8.&nbsp;&nbsp;&nbsp;&nbsp;<u>Governing Law</u>. THIS AMENDMENT SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAW OF THE STATE OF NEW YORK.

SECTION 9.&nbsp;&nbsp;&nbsp;&nbsp;<u>Counterparts</u>. This Amendment may be executed in any number of counterparts and by the different parties hereto on separate counterparts, each of which counterparts when executed and delivered shall be an original, but all of which shall together constitute one and the same instrument. Delivery by facsimile or electronic transmission of an executed counterpart of a signature page to this Amendment shall be effective as delivery of an original executed counterpart of this Amendment. The words "execution," "signed," "signature," and words of like import in this Amendment shall be deemed to include electronic signatures or electronic records, each of which shall be of the same legal effect, validity or enforceability as a manually executed signature or the use of a paper-based recordkeeping system, as the case may be, to the extent and as provided for in any applicable law, including the Federal Electronic Signatures in Global and National Commerce Act, the New York State Electronic Signatures and Records Act, or any other similar state laws based on the Uniform Electronic Transactions Act.

[The remainder of this page is intentionally left blank.]

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

217041600_5

------

IN WITNESS WHEREOF, the parties hereto have caused their duly authorized officers to execute and deliver this Amendment as of the date first above written.

<u>BORROWERS</u>:

SILGAN HOLDINGS INC., as US Borrower

By:&nbsp;&nbsp;&nbsp;&nbsp;<u>/s/ Frank W. Hogan, III</u><br> Name:&nbsp;&nbsp;&nbsp;&nbsp;Frank W. Hogan, III<br> Title:&nbsp;&nbsp;&nbsp;&nbsp;Executive Vice President, General Counsel and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Secretary

SILGAN CONTAINERS LLC

SILGAN PLASTICS LLC

SILGAN CONTAINERS MANUFACTURING CORPORATION

SILGAN DISPENSING SYSTEMS HOLDINGS COMPANY, as US Borrowers

By: <u>/s/ Frank W. Hogan, III</u><br> Name: Frank W. Hogan, III<br> Title: Vice President and Secretary

SILGAN INTERNATIONAL HOLDINGS B.V., as a Dutch Borrower

By:&nbsp;&nbsp;&nbsp;&nbsp;<u>/s/ Frank W. Hogan, III</u><br> Name:&nbsp;&nbsp;&nbsp;&nbsp;Frank W. Hogan, III<br> Title: &nbsp;&nbsp;&nbsp;&nbsp;Authorized Representative

Silgan Holdings Inc.

Sixth Amendment to Amended and Restated Credit Agreement

Signature Page

------

<u>GUARANTORS</u>:

SILGAN HOLDINGS INC., as a Guarantor

By:&nbsp;&nbsp;&nbsp;&nbsp;<u>/s/ Frank W. Hogan, III</u><br> Name:&nbsp;&nbsp;&nbsp;&nbsp;Frank W. Hogan, III<br> Title:&nbsp;&nbsp;&nbsp;&nbsp;Executive Vice President, General Counsel and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Secretary

SILGAN HOLDINGS LLC

SILGAN CORPORATION, each as a Guarantor

By: <u>/s/ Frank W. Hogan, III</u><br> Name: Frank W. Hogan, III<br> Title: Executive Vice President, General Counsel and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Secretary

Silgan Holdings Inc.

Sixth Amendment to Amended and Restated Credit Agreement

Signature Page

------

SILGAN CONTAINERS LLC

SILGAN PLASTICS LLC

SILGAN CONTAINERS MANUFACTURING CORPORATION

SILGAN EQUIPMENT COMPANY

SILGAN PLASTICS CORPORATION

SILGAN WHITE CAP LLC

SILGAN WHITE CAP CORPORATION

SILGAN WHITE CAP AMERICAS LLC

SILGAN TUBES HOLDING COMPANY

SILGAN IPEC CORPORATION

SILGAN PLASTIC FOOD CONTAINERS CORPORATION

PORTOLA PACKAGING LLC

SILGAN DISPENSING SYSTEMS CORPORATION

SILGAN DISPENSING SYSTEMS SLATERSVILLE LLC

SILGAN DISPENSING SYSTEMS HOLDINGS COMPANY

SILGAN DISPENSING SYSTEMS THOMASTON CORPORATION

SILGAN DISPENSING SYSTEMS METAL HOLDINGS CORPORATION

SILGAN DISPENSING SYSTEMS METAL REAL ESTATE CORPORATION

SILGAN DISPENSING SYSTEMS COVIT AMERICA CORPORATION

SILGAN SPECIALTY PACKAGING LLC

SILGAN UNICEP PACKAGING LLC

SILGAN SPECIALTY PACKAGING TRIADELPHIA LLC, each as a Guarantor

By: <u>/s/ Frank W. Hogan, III</u><br> Name: Frank W. Hogan, III<br> Title: Vice President and Secretary

Silgan Holdings Inc.

Sixth Amendment to Amended and Restated Credit Agreement

Signature Page

------

SILGAN HOLDINGS INC., in its capacity as general partner of SILGAN PARTNERSHIP C.V., as a Guarantor

By: <u>/s/ Frank W. Hogan, III</u><br> Name: Frank W. Hogan, III<br> Title: Executive Vice President, General Counsel and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Secretary

Silgan Holdings Inc.

Sixth Amendment to Amended and Restated Credit Agreement

Signature Page

------

WELLS FARGO BANK, NATIONAL ASSOCIATION, as Administrative Agent, Swingline Lender, Collateral Agent, an Issuing Lender and a Lender

By:&nbsp;&nbsp;&nbsp;&nbsp;<u>/s/ Andrew Payne</u>

Name:&nbsp;&nbsp;&nbsp;&nbsp;Andrew Payne

Title:&nbsp;&nbsp;&nbsp;&nbsp;Managing Director

Silgan Holdings Inc.

Sixth Amendment to Amended and Restated Credit Agreement

Signature Page

------

COBANK, ACB, as a Lender

By:&nbsp;&nbsp;&nbsp;&nbsp;<u>/s/ Matthew Brill</u>

Name:&nbsp;&nbsp;&nbsp;&nbsp;Matthew Brill

Title:&nbsp;&nbsp;&nbsp;&nbsp;Vice President

Silgan Holdings Inc.

Sixth Amendment to Amended and Restated Credit Agreement

Signature Page

------

BANK OF AMERICA, N.A., as a Lender and an Issuing Lender

By:&nbsp;&nbsp;&nbsp;&nbsp;<u>/s/ Daniel Phelan</u> 

Name:&nbsp;&nbsp;&nbsp;&nbsp;Daniel Phelan

Title:&nbsp;&nbsp;&nbsp;&nbsp;Director

Silgan Holdings Inc.

Sixth Amendment to Amended and Restated Credit Agreement

Signature Page

------

MIZUHO BANK, LTD., as a Lender and an Issuing Lender

By:&nbsp;&nbsp;&nbsp;&nbsp;<u>/s/ Donna DeMagistris</u>

Name:&nbsp;&nbsp;&nbsp;&nbsp;Donna DeMagistris

Title:&nbsp;&nbsp;&nbsp;&nbsp;Managing Director

Silgan Holdings Inc.

Sixth Amendment to Amended and Restated Credit Agreement

Signature Page

------

JPMORGAN CHASE BANK, N.A., as a Lender and an Issuing Lender

By:&nbsp;&nbsp;&nbsp;&nbsp;<u>/s/ Gus Huerta</u>

Name:&nbsp;&nbsp;&nbsp;&nbsp;Gus Huerta

Title:&nbsp;&nbsp;&nbsp;&nbsp;Authorized Officer

Silgan Holdings Inc.

Sixth Amendment to Amended and Restated Credit Agreement

Signature Page

------

TRUIST BANK, as a Lender and an Issuing Lender

By:&nbsp;&nbsp;&nbsp;&nbsp;<u>/s/ Chris Hursey</u>

Name:&nbsp;&nbsp;&nbsp;&nbsp;Chris Hursey

Title:&nbsp;&nbsp;&nbsp;&nbsp;Director

Silgan Holdings Inc.

Sixth Amendment to Amended and Restated Credit Agreement

Signature Page

------

COÖPERATIEVE RABOBANK U.A., NEW YORK BRANCH, as a Lender and an Issuing Lender

By:&nbsp;&nbsp;&nbsp;&nbsp;<u>/s/ Jennifer Smith</u>

Name:&nbsp;&nbsp;&nbsp;&nbsp;Jennifer Smith

Title:&nbsp;&nbsp;&nbsp;&nbsp;Executive Director

By:&nbsp;&nbsp;&nbsp;&nbsp;<u>/s/ Drew Prather</u>

Name:&nbsp;&nbsp;&nbsp;&nbsp;Drew Prather

Title:&nbsp;&nbsp;&nbsp;&nbsp;Vice President

Silgan Holdings Inc.

Sixth Amendment to Amended and Restated Credit Agreement

Signature Page

------

SUMITOMO MITSUI BANKING CORPORATION, as a Lender and an Issuing Lender

By:&nbsp;&nbsp;&nbsp;&nbsp;<u>/s/ Minxiao Tian</u>

Name:&nbsp;&nbsp;&nbsp;&nbsp;Minxiao Tian

Title:&nbsp;&nbsp;&nbsp;&nbsp;Director

Silgan Holdings Inc.

Sixth Amendment to Amended and Restated Credit Agreement

Signature Page

------

U.S. BANK NATIONAL ASSOCIATION, as a Lender

By:&nbsp;&nbsp;&nbsp;&nbsp;<u>/s/ Sawyer Johnson</u>

Name:&nbsp;&nbsp;&nbsp;&nbsp;Sawyer Johnson

Title:&nbsp;&nbsp;&nbsp;&nbsp;Vice President

Silgan Holdings Inc.

Sixth Amendment to Amended and Restated Credit Agreement

Signature Page

------

GOLDMAN SACHS BANK USA, as a Lender and an Issuing Lender

By:&nbsp;&nbsp;&nbsp;&nbsp;<u>/s/ Dan Matis</u>

Name:&nbsp;&nbsp;&nbsp;&nbsp;Dan Matis

Title:&nbsp;&nbsp;&nbsp;&nbsp;Authorized Signatory

Silgan Holdings Inc.

Sixth Amendment to Amended and Restated Credit Agreement

Signature Page

------

M&T BANK, as a Lender

By:&nbsp;&nbsp;&nbsp;&nbsp;<u>/s/ Donna J. Emhart</u>

Name:&nbsp;&nbsp;&nbsp;&nbsp;Donna J. Emhart

Title:&nbsp;&nbsp;&nbsp;&nbsp;Director

Silgan Holdings Inc.

Sixth Amendment to Amended and Restated Credit Agreement

Signature Page

------

MORGAN STANLEY BANK, N.A., as a Lender and an Issuing Lender

By:&nbsp;&nbsp;&nbsp;&nbsp;<u>/s/ Aaron McLean</u>

Name:&nbsp;&nbsp;&nbsp;&nbsp;Aaron McLean

Title:&nbsp;&nbsp;&nbsp;&nbsp;Authorized Signatory

Silgan Holdings Inc.

Sixth Amendment to Amended and Restated Credit Agreement

Signature Page

------

BANK OF CHINA LIMITED, NEW YORK BRANCH, as a Lender

By:&nbsp;&nbsp;&nbsp;&nbsp;<u>/s/ Raymond Qiao</u>

Name:&nbsp;&nbsp;&nbsp;&nbsp;Raymond Qiao

Title:&nbsp;&nbsp;&nbsp;&nbsp;Executive Vice President

Silgan Holdings Inc.

Sixth Amendment to Amended and Restated Credit Agreement

Signature Page

------

FIFTH THIRD BANK, NATIONAL ASSOCIATION, as a Lender

By:&nbsp;&nbsp;&nbsp;&nbsp;<u>/s/ James Disher</u>

Name:&nbsp;&nbsp;&nbsp;&nbsp;James Disher

Title:&nbsp;&nbsp;&nbsp;&nbsp;Senior Vice President

Silgan Holdings Inc.

Sixth Amendment to Amended and Restated Credit Agreement

Signature Page

------

THE BANK OF NOVA SCOTIA, as a Lender

By:&nbsp;&nbsp;&nbsp;&nbsp;<u>/s/ Catherine B. Jones</u>

Name:&nbsp;&nbsp;&nbsp;&nbsp;Catherine B. Jones

Title:&nbsp;&nbsp;&nbsp;&nbsp;Managing Director

Silgan Holdings Inc.

Sixth Amendment to Amended and Restated Credit Agreement

Signature Page

------

CITY NATIONAL BANK, as a Lender

By:&nbsp;&nbsp;&nbsp;&nbsp;<u>/s/ Louis Serio</u>

Name:&nbsp;&nbsp;&nbsp;&nbsp;Louis Serio

Title:&nbsp;&nbsp;&nbsp;&nbsp;SVP

Silgan Holdings Inc.

Sixth Amendment to Amended and Restated Credit Agreement

Signature Page

------

RAIFFEISEN BANK INTERNATIONAL AG, as a Lender

By:&nbsp;&nbsp;&nbsp;&nbsp;<u>/s/ Erik Schnetzer</u>

Name:&nbsp;&nbsp;&nbsp;&nbsp;Erik Schnetzer

Title:&nbsp;&nbsp;&nbsp;&nbsp;Director

By:&nbsp;&nbsp;&nbsp;&nbsp;<u>/s/ Stefan Bauer</u>

Name:&nbsp;&nbsp;&nbsp;&nbsp;Stefan Bauer

Title:&nbsp;&nbsp;&nbsp;&nbsp;Director

Silgan Holdings Inc.

Sixth Amendment to Amended and Restated Credit Agreement

Signature Page

------

BANCO DE SABADELL, S.A., - MIAMI BRANCH, as a Lender

By:&nbsp;&nbsp;&nbsp;&nbsp;<u>/s/ Enrique Castillo</u>

Name:&nbsp;&nbsp;&nbsp;&nbsp;Enrique Castillo

Title:&nbsp;&nbsp;&nbsp;&nbsp;Head of Corporate Banking

Silgan Holdings Inc.

Sixth Amendment to Amended and Restated Credit Agreement

Signature Page

------

HUA NAN COMMERCIAL BANK, LTD. NEW YORK AGENCY, as a Lender

By:&nbsp;&nbsp;&nbsp;&nbsp;<u>/s/ Tzu I Huang</u>

Name:&nbsp;&nbsp;&nbsp;&nbsp;Tzu I Huang

Title:&nbsp;&nbsp;&nbsp;&nbsp;Vice President & General Manager

Silgan Holdings Inc.

Sixth Amendment to Amended and Restated Credit Agreement

Signature Page

------

FIRST COMMERCIAL BANK, LTD. LOS ANGELES BRANCH, as a Lender

By:&nbsp;&nbsp;&nbsp;&nbsp;<u>/s/ Alan Huang</u>

Name:&nbsp;&nbsp;&nbsp;&nbsp;Alan Huang

Title:&nbsp;&nbsp;&nbsp;&nbsp;V.P. & General Manager

Silgan Holdings Inc.

Sixth Amendment to Amended and Restated Credit Agreement

Signature Page

------

MEGA INTERNATIONAL COMMERCIAL BANK CO., LTD., as a Departing Lender

By:&nbsp;&nbsp;&nbsp;&nbsp;<u>/s/ Pei Chen Wang</u>

Name:&nbsp;&nbsp;&nbsp;&nbsp;Pei Chen Wang

Title:&nbsp;&nbsp;&nbsp;&nbsp;Vice President & General Manager

Silgan Holdings Inc.

Sixth Amendment to Amended and Restated Credit Agreement

Signature Page

------

The Toronto-Dominion Bank, New York Branch, as a Departing Lender

By:&nbsp;&nbsp;&nbsp;&nbsp;<u>/s/ David Perlman</u>

Name:&nbsp;&nbsp;&nbsp;&nbsp;David Perlman

Title:&nbsp;&nbsp;&nbsp;&nbsp;Authorized Signatory

Silgan Holdings Inc.

Sixth Amendment to Amended and Restated Credit Agreement

Signature Page

------

<u>ANNEX A</u>

<u>COMMITMENTS</u>

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Lender** | **Revolving Loan Commitment** | **US A-1 Term Loan Commitment** | **US A-2 Term Loan Commitment** | **Euro A-3 Term Loan Commitment** |
| Wells Fargo Bank, National Association | $170450000.00 | $99792000.00 | $0.00 | €111,300,000.00 |
| CoBank, ACB | $328300000.00 | $0.00 | $184898000.00 | €0.00 |
| Bank of America, N.A. | $161850000.00 | $95186000.00 | $0.00 | €106,350,000.00 |
| Mizuho Bank, Ltd. | $161700000.00 | $90992000.00 | $0.00 | €94,050,000.00 |
| JPMorgan Chase Bank, N.A. | $60000000.00 | $33840000.00 | $0.00 | €106,500,000.00 |
| Truist Bank | $60000000.00 | $33840000.00 | $0.00 | €94,050,000.00 |
| Coöperatieve Rabobank U.A., New York Branch | $60000000.00 | $33840000.00 | $0.00 | €74,250,000.00 |
| Sumitomo Mitsui Banking Corporation | $60000000.00 | $33840000.00 | $0.00 | €69,300,000.00 |
| U.S. Bank National Association | $90000000.00 | $25568000.00 | $0.00 | €27,300,000.00 |
| Goldman Sachs Bank USA | $60300000.00 | $34758000.00 | $0.00 | €39,600,000.00 |
| M&T Bank | $45300000.00 | $25568000.00 | $0.00 | €39,600,000.00 |
| Morgan Stanley Bank, N.A. | $65000000.00 | $0.00 | $0.00 | €39,600,000.00 |
| Bank of China Limited, New York Branch | $31300000.00 | $17578000.00 | $0.00 | €39,600,000.00 |
| Fifth Third Bank, National Association | $45300000.00 | $25568000.00 | $0.00 | €0.00 |
| The Bank of Nova Scotia | $39500000.00 | $0.00 | $0.00 | €19,800,000.00 |
| City National Bank | $24700000.00 | $13912000.00 | $0.00 | €19,800,000.00 |
| Raiffeisen Bank International AG | $36300000.00 | $6298000.00 | $0.00 | €0.00 |
| Banco de Sabadell, S.A., Miami Branch | $0.00 | $13160000.00 | $0.00 | €9,900,000.00 |
| Hua Nan Commercial Bank, Ltd. New York Agency | $0.00 | $16262000.00 | $0.00 | €0.00 |
| First Commercial Bank, Ltd. Los Angeles Branch | $0.00 | $14100000.00 | $0.00 | €0.00 |
| **Total** | **$1500000000.00** | **$614102000.00** | **$184898000.00** | **€891,000,000.00** |

---

217041600_5

## Exhibit 10.2

**Exhibit 10.2**

**OFFICER AGREEMENT**

THIS AGREEMENT ("**Agreement**") is made and entered into as of this 6<sup>th</sup> day of November, 2025 ("**Effective Date**"), by and between Silgan Holdings Inc. ("**Company**") and Alexander G. Hutter ("**Officer**"). For purposes of this Agreement, the term "**Company**" shall include all subsidiaries of Silgan Holdings Inc. as well as all future subsidiaries of Silgan Holdings Inc.

**&nbsp;&nbsp;&nbsp;&nbsp;<u>RECITALS</u>**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A. &nbsp;&nbsp;&nbsp;&nbsp;Company is engaged in the business of developing, creating, manufacturing and selling, among other things, (i) dispensing systems and metal and plastic closures for consumer goods products including fragrance and beauty, food, beverage, personal and health care, home care and lawn and garden products, (ii) metal containers for human and pet food and other products, and (iii) plastic packaging solutions for consumer goods products including human and pet food, consumer health and pharmaceutical, personal care, home care, lawn and garden and automotive products (collectively, the "**Business**"). Company's headquarters and principal place of business are located in, and this Agreement is being signed in, Norwalk, Connecticut.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;B.&nbsp;&nbsp;&nbsp;&nbsp;Officer will be an officer of Company who is involved in, and has significant responsibilities and confidential information regarding, Company's Business.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;C.&nbsp;&nbsp;&nbsp;&nbsp;Company desires that Officer sign this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;D.&nbsp;&nbsp;&nbsp;&nbsp;Officer desires to sign this Agreement and be eligible for severance as provided herein.

NOW, THEREFORE, in consideration of the above and of the mutual covenants and agreements hereinafter set forth, Officer and Company agree as follows:

1.&nbsp;&nbsp;&nbsp;&nbsp;<u>Confidential Information</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;Officer agrees to keep secret and confidential, and not to use or disclose to any third-parties, except as directly required for Officer to perform Officer's employment responsibilities for Company, any of Company's confidential, proprietary and/or trade secret information concerning Company's Business learned, developed or otherwise acquired by Officer during the course of, or in connection with, Officer's employment with Company ("**Confidential Information**"). Confidential Information includes, among other things, Company's confidential information regarding its customers and prospective customers (including but not limited to their needs, preferences, requirements, and likes and dislikes), costs, pricing, profitability, sales and marketing strategies, pricing policies, commission structures, contract terms and conditions, operational methods, strategic plans, nonpublic personnel-related information, nonpublic training materials, internal financial information, research and development plans and activities, and the like. Officer acknowledges that Company exercises

------

reasonable efforts to maintain the secrecy and confidentiality of Confidential Information, and Officer agrees to treat Confidential Information as secret and confidential so long as such information is not generally known to the public.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;Officer acknowledges that any and all notes, records, sketches, external storage devices, nonpublic training materials, recordings and other documents obtained by or provided to Officer, or otherwise made, produced or compiled during the course of Officer's employment with Company, which contain any Confidential Information of Company, regardless of the type of medium in which it is preserved, are the sole and exclusive property of Company and shall be given to Company (with no copies retained) upon Officer's termination of employment or on demand at any time by Company.

2.&nbsp;&nbsp;&nbsp;&nbsp;<u>Restrictions during Employment</u>. Officer agrees that throughout Officer's employment with Company, Officer shall (a) faithfully render such services as may be delegated to Officer by Company; (b) devote Officer's entire business time, good faith, best efforts, ability, skill and attention to Company's Business; (c) not, directly or indirectly, compete, plan or prepare to compete, or assist anyone else in competing or in planning or preparing to compete, against Company; and (d) follow and act in accordance with all of Company's rules, policies and procedures with respect to the operation of Company.

3.&nbsp;&nbsp;&nbsp;&nbsp;<u>Post-Termination Restrictions</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;Officer recognizes that (1) Company has spent substantial money, time and effort over the years in developing and solidifying its relationships with its customers and in developing its Confidential Information; (2) long-term customer relationships often can be difficult to develop and require a significant investment of time, effort and expense; and (3) Company pays its high-level personnel such as Officer to, among other things, develop and preserve Confidential Information, customer goodwill, and customer loyalty for and on behalf of Company. Accordingly, Officer agrees that for a period of one (1) year immediately following Officer's last day of employment with Company if such employment is terminated by Company with or without cause or by Officer, Officer shall not, directly or indirectly, on Officer's behalf or on behalf of any other person, firm, corporation, partnership or other entity, compete against Company by:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;&nbsp;&nbsp;&nbsp;providing, or supervising, managing or consulting in the provision of, any services or products that are competitive with Company's Business;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)&nbsp;&nbsp;&nbsp;&nbsp;becoming employed by, or providing services under contract or otherwise for, any company providing services or products in competition with Company's Business;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)&nbsp;&nbsp;&nbsp;&nbsp;providing, or supervising, managing or consulting in the provision of, any work or activity that involves a product, process, apparatus, service or development utilized by the Company in its Business to any customer of Company with whom Officer or anyone under Officer's direct supervision dealt at any time

&nbsp;&nbsp;&nbsp;&nbsp;-2-&nbsp;&nbsp;&nbsp;&nbsp;

------

during Officer's last two (2) years of employment with Company or about whom Officer acquired any Confidential Information while Officer was employed by Company;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv)&nbsp;&nbsp;&nbsp;&nbsp;soliciting, enticing, inducing, hiring, employing or seeking to employ any salesperson, engineer, technician, manager or executive-level employee of Company, who was employed by Company during Officer's last six (6) months of employment with the Company, to provide any services in competition with Company's Business.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;The post-termination restrictions in Sections 3(a)(i) and (ii) above shall apply only in the United States, Canada, and such other countries where Company is engaged in the Business, or is actively planning to engage in the Business, as of the last day of Officer's employment with Company. Officer acknowledges and agrees that the post-termination restrictions in Sections 3(a)(i) through (iv) above are reasonable and necessary to protect Company's legitimate protectible interests because, among other reasons, (i) of the narrow range of the activities prohibited; (ii) of the Confidential Information to which Officer has and will have access, which Officer agrees can have a useful competitive life of more than two years; (iii) of Officer's high-level position in Company, which provides Officer with access to Company's most sensitive Confidential Information and access to and influence regarding Company's most valuable and sensitive customer relationships; (iv) above there are many other areas and businesses in which, and companies for which, Officer could work in view of Officer's background, and the restraints contained herein therefore should not impose any undue hardship on Officer. Officer further acknowledges and agrees that the restrictions in Section 3(a)(iv) above are reasonable because (1) Officer, as a high-level employee, is in a position to identify, through Confidential Information, Company employees most integral and/or critical to the success of Company's Business; (2) such restrictions protect against the possible loss or misuse of Confidential Information by other Company employees; (3) such restrictions protect the customer relationships and/or goodwill associated with other Company employees; and (4) loss of one or more other Company employees, in addition to Officer, would increase the risk of loss or misuse of Confidential Information and/or customer relationships.

4.&nbsp;&nbsp;&nbsp;&nbsp;<u>Intellectual Property</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;Officer agrees that any and all Confidential Information, ideas, inventions, discoveries, patents, patent applications, technology, improvements, know-how, copyrights, tangible works of expression, derivative works, trademarks, service marks, trade secrets, and the like ("**Intellectual Property**"), which are developed, conceived, created, discovered, learned, produced and/or otherwise generated by Officer, whether individually or otherwise, during the time that Officer is employed by Company, whether before or after execution of this Agreement, whether or not during working hours, that relate to: (a) current and anticipated businesses and/or activities of Company; (b) Company's current and anticipated research or development; or (c) any

&nbsp;&nbsp;&nbsp;&nbsp;-3-&nbsp;&nbsp;&nbsp;&nbsp;

------

work performed by Officer for Company are and shall be the sole and exclusive property of Company, and Company shall own any and all worldwide right, title and interest in, to and under such Intellectual Property. Officer hereby agrees to assign, and assigns, to Company any and all worldwide right, title and interest in, to and under such Intellectual Property. Officer hereby agrees, whenever requested to do so by Company, at Company's expense, to execute any and all applications, assignments or other instruments which Company deems desirable or necessary to protect such interests. In the event that Company requests Officer to perform any of the foregoing services following termination of Officer's employment with Company, Company agrees to compensate Officer for such services at a rate per hour equal to the base salary that Officer received from Company at the time of Officer's termination. In addition, Company shall reimburse Officer for all related reasonable out-of-pocket expenses incurred in rendering such services. Officer further agrees to make a complete written disclosure to Company of any Intellectual Property, when and as it arises, is conceived or is reduced to practice, specifically pointing out the features or concepts that Officer believes to be new or different.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;Officer agrees that any Intellectual Property that is conceived, developed, or reduced to practice by Officer within one (1) year immediately following the termination of Officer's employment with Company that relates to the actual or foreseeable Business of Company will be presumed to have been made during the term of Officer's employment and will be the sole property of Company, unless Officer presents sufficient evidence to Company satisfactory to rebut the presumption.

5.&nbsp;&nbsp;&nbsp;&nbsp;<u>Non-Waiver of Rights</u>. Company's failure to enforce at any time any of the provisions of this Agreement or to require at any time performance by Officer of any of the provisions hereof shall in no way be construed to be a waiver of such provisions or to affect either the validity of this Agreement, or any part hereof, or the right of Company thereafter to enforce each and every provision in accordance with the terms of this Agreement.

6.&nbsp;&nbsp;&nbsp;&nbsp;<u>Invalidity of Provisions</u>. If any provision of this Agreement is adjudicated to be invalid or unenforceable under applicable law in any jurisdiction, the validity or enforceability of the remaining provisions thereof shall be unaffected as to such jurisdiction and such adjudication shall not affect the validity or enforceability of such provisions in any other jurisdiction. To the extent that any provision of this Agreement is adjudicated to be invalid or unenforceable because it is overbroad, that provision shall not be void but rather shall be limited only to the extent required by applicable law and enforced as so limited.

7.&nbsp;&nbsp;&nbsp;&nbsp;<u>Assignments</u>. This Agreement shall be freely assignable by Company to and shall inure to the benefit of, and be binding upon, any other entity which shall succeed to the Business. Being a contract for personal services, neither this Agreement nor any rights hereunder shall be assigned by Officer.

8.&nbsp;&nbsp;&nbsp;&nbsp;<u>Company's Right to Recover Costs and Fees</u>. If Officer breaches or threatens to breach this Agreement, Officer shall be liable for any attorneys' fees and costs incurred by Company in enforcing its rights hereunder. In addition, Officer agrees that upon any breach by Officer of

&nbsp;&nbsp;&nbsp;&nbsp;-4-&nbsp;&nbsp;&nbsp;&nbsp;

------

this Agreement the Company will cease making any further Severance Payments (as defined in Section 9(b) below) hereunder and Officer shall immediately reimburse the Company for all Severance Payments (as defined in Section 9(b) below) paid to Officer by the Company.

9.&nbsp;&nbsp;&nbsp;&nbsp;<u>Termination</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;Officer's employment with Company is terminable by Company, or by Officer, without cause, at any time upon notice to the other party. Company also may terminate Officer's employment with Company immediately for cause at any time. If Officer's employment with Company is terminated, for any reason, with or without cause, Company shall have no liability whatsoever to Officer other than to pay Officer the compensation due through Officer's last day of employment (subject to Subsection (b) below), and such termination shall not diminish or affect in any way Officer's post-employment duties and obligations under this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;Officer acknowledges that Officer is, and at all times will be, an employee-at-will of Company and nothing herein shall be construed to alter or affect such employee-at-will status. Without limiting the generality of the foregoing, as additional consideration for Officer's execution of this Agreement and Officer's execution at the time of termination of employment of a separation and release agreement reasonably satisfactory to Company, in the event that Company terminates Officer's employment without cause, Company hereby agrees to provide Officer with a payment of an amount equal to one (1) year of Officer's normal base salary at Officer's then annual salary rate less applicable withholdings (the "**Severance Payment**"), with payment of the Severance Payment to be made in equal monthly installments over the course of the one (1) year period following the effective date of termination. Officer understands, acknowledges and agrees that no Severance Payment shall be due in the event that Company terminates Officer's employment for cause or Officer terminates his employment.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;&nbsp;&nbsp;&nbsp;For purposes of this Agreement, "cause" shall mean and include Officer's (i) act of fraud, embezzlement, theft, bribery or any other act of comparable dishonesty, disloyalty or breach of trust against the Company or any other material violation of law that occurs during or in the course of Officer's employment with Company; (ii) damage to Company's assets; (iii) improper use or disclosure of Company's confidential information; (iv) breach of Officer's obligations under this Agreement; (v) engagement in, or the planning of or preparation for, any competitive activity which would constitute a breach of Officer's duty of loyalty or of Officer's obligations under this Agreement; (vi) breach of any of Company's policies; (vii) willful and continued failure to perform Officer's duties for Company (other than as a result of incapacity due to physical or mental illness); or (viii) willful conduct that is injurious to Company, monetarily or otherwise.

10.&nbsp;&nbsp;&nbsp;&nbsp;<u>Amendments</u>. No modification or amendment of any of the provisions of this Agreement shall be effective unless in writing specifically referring hereto, and signed by the parties hereto. This Agreement supersedes all prior agreements and understandings between Officer

&nbsp;&nbsp;&nbsp;&nbsp;-5-&nbsp;&nbsp;&nbsp;&nbsp;

------

and Company to the extent that any such agreements or understandings conflict with the terms of this Agreement.

11.&nbsp;&nbsp;&nbsp;&nbsp;<u>Choice of Forum and Governing Law</u>. The parties acknowledge and recognize the substantial contacts that they have and will continue to have with Connecticut. Such contacts may include the following: Company has its headquarters in Connecticut; Officer will perform Officer's employment duties in Connecticut; Officer will deal with, report directly or indirectly to and/or receive strategic and/or management guidance or direction from executive-level personnel based in Connecticut; Officer will attend meetings in Connecticut at which Confidential Information may be disclosed; Officer will receive or be sent Confidential Information originating from Company in Connecticut; this Agreement was formed in, accepted, and executed in Connecticut; and the parties' expectations under this Agreement are based on Connecticut law. In light of the parties' substantial contacts with the State of Connecticut, and their significant interest in ensuring that disputes as to the validity and enforceability of this Agreement are resolved on a uniform basis, the parties agree that: (a) any litigation involving any noncompliance with or breach of the Agreement, or regarding the interpretation, validity and/or enforceability of the Agreement, shall be filed and conducted exclusively in Stamford, Connecticut; and (b) the Agreement shall be interpreted in accordance with and governed by the laws of the State of Connecticut, without regard for any conflict of law principles.

12.&nbsp;&nbsp;&nbsp;&nbsp;<u>Company's Right to Injunctive Relief</u>. In the event of a breach or threatened breach of any of Officer's duties and obligations under the terms and provisions of Sections 1, 2, 3, 4 or 11 hereof, Company shall be entitled, in addition to any other legal or equitable remedies it may have in connection therewith (including any right to damages that it may suffer), to temporary, preliminary and permanent injunctive relief restraining such breach or threatened breach. Officer hereby expressly acknowledges that the harm which might result to the Business as a result of any noncompliance by Officer with any of the provisions of Sections 1, 2, 3, 4 or 11 would be largely irreparable. Officer specifically agrees that if there is a question as to the enforceability or interpretation of any of the provisions of Sections 1, 2, 3, 4 or 11 hereof, Officer will not engage in any conduct inconsistent with or contrary to such Sections or Company's good faith interpretation thereof until after the question has been resolved by a final judgment of a court of competent jurisdiction. Any time during which Officer violates any restrictions on Officer under this Agreement shall not count toward satisfying the time during which such restrictions shall apply.

13.&nbsp;&nbsp;&nbsp;&nbsp;<u>Future Employment</u>. Officer shall disclose the existence of this Agreement to any new employer that offers products or services that compete with the Business. Officer shall not, during or after employment with Company, make any comments or other communications disparaging the goodwill or reputation of Company, its employees or Business. Officer consents to Company informing any subsequent employer of Officer, or any entity which Company in good faith believes is, or is likely to be, considering employing Officer, of the existence and terms of this Agreement.

14.&nbsp;&nbsp;&nbsp;&nbsp;<u>Transfers</u>. This Agreement shall continue and be in full force and effect without re-execution in the event Officer is employed by Company in another position or location.

&nbsp;&nbsp;&nbsp;&nbsp;-6-&nbsp;&nbsp;&nbsp;&nbsp;

------

**<u>PLEASE NOTE</u>: BY SIGNING THIS AGREEMENT, OFFICER IS HEREBY CERTIFYING THAT OFFICER (A) HAS RECEIVED A COPY OF THIS AGREEMENT FOR REVIEW AND STUDY BEFORE EXECUTING IT; (B) HAS READ THIS AGREEMENT CAREFULLY BEFORE SIGNING IT; (C) HAS HAD SUFFICIENT OPPORTUNITY BEFORE SIGNING THE AGREEMENT TO ASK ANY QUESTIONS OFFICER HAS ABOUT THE AGREEMENT AND HAS RECEIVED SATISFACTORY ANSWERS TO ALL SUCH QUESTIONS; AND (D) UNDERSTANDS OFFICER'S RIGHTS AND OBLIGATIONS UNDER THE AGREEMENT.**

IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be executed as of the Effective Date first above written.

<u>/s/ Alexander G. Hutter&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u>

Officer: <u>Alexander G. Hutter&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u>

Address: <u>&nbsp;&nbsp;&nbsp;&nbsp; [Redacted]&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u>

<u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u>

SILGAN HOLDINGS INC.

By:<u>&nbsp;&nbsp;&nbsp;&nbsp;/s/ Frank W. Hogan, III&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u>

Name:<u>&nbsp;&nbsp;&nbsp;&nbsp; Frank W. Hogan, III&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u>

Title:<u>&nbsp;&nbsp;&nbsp;&nbsp;Executive Vice President, General&nbsp;&nbsp;&nbsp;&nbsp;</u>&nbsp;&nbsp;&nbsp;&nbsp;

<u>Counsel and Secretary&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u>

&nbsp;&nbsp;&nbsp;&nbsp;-7-&nbsp;&nbsp;&nbsp;&nbsp;

## Exhibit 31.1

**Exhibit 31.1**

**CERTIFICATION BY THE CHIEF EXECUTIVE OFFICER**

**PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT**

I, Adam J. Greenlee, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q for the period ended March 31, 2026 of Silgan Holdings Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c. Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d. Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | |
|:---|:---|
| Date: May 6, 2026 | <u>/s/ Adam J. Greenlee</u> |
| | Adam J. Greenlee |
| | Chief Executive Officer and President |

---

## Exhibit 31.2

**Exhibit 31.2**

**CERTIFICATION BY THE CHIEF FINANCIAL OFFICER**

**PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT**

I, Shawn C. Fabry, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q for the period ended March 31, 2026 of Silgan Holdings Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c. Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d. Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | |
|:---|:---|
| Date: May 6, 2026 | <u>/s/ Shawn C. Fabry</u> |
| | Shawn C. Fabry |
| | Executive Vice President and |
| | Chief Financial Officer |

---

## Exhibit 32.1

**Exhibit 32.1**

**CERTIFICATION BY THE CHIEF EXECUTIVE OFFICER**

**PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT**

In connection with the Quarterly Report of Silgan Holdings Inc. (the "Company") on Form 10-Q for the period ended March 31, 2026 as filed with the Securities and Exchange Commission on the date hereof (the "Quarterly Report"), I, Adam J. Greenlee, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

---

| |
|:---|
| (1) The Quarterly Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
| (2) The information contained in the Quarterly Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |

---

---

| |
|:---|
| <u>/s/ Adam J. Greenlee</u> |
| Adam J. Greenlee |
| Chief Executive Officer and President |

---

May 6, 2026

A signed original of this written statement required by Section 906 has been provided to Silgan Holdings Inc. and will be retained by Silgan Holdings Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

## Exhibit 32.2

**Exhibit 32.2**

**CERTIFICATION BY THE CHIEF FINANCIAL OFFICER**

**PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT**

In connection with the Quarterly Report of Silgan Holdings Inc. (the "Company") on Form 10-Q for the period ended March 31, 2026 as filed with the Securities and Exchange Commission on the date hereof (the "Quarterly Report"), I, Shawn C. Fabry, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

---

| |
|:---|
| (1) The Quarterly Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
| (2) The information contained in the Quarterly Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |

---

---

| |
|:---|
| <u>/s/ Shawn C. Fabry</u> |
| Shawn C. Fabry |
| Executive Vice President and |
| Chief Financial Officer |

---

May 6, 2026

A signed original of this written statement required by Section 906 has been provided to Silgan Holdings Inc. and will be retained by Silgan Holdings Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

<br>